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Abstract
Stigma is a complex issue that can significantly affect people with serious mental illness (SMI)
and older adults due to their increased risk of cognitive deficits and somatic conditions. Both of
these populations can experience stigma from healthcare providers, which may serve as a barrier
to seeking and remaining in treatment, and contribute to inequality in the amount and quality of
treatment these populations receive. The present study partially replicated previous research by
assessing if healthcare providers have more stigmatizing attitudes and are less likely to provide
referrals to patients with SMI compared to patient’s without SMI. This study also extended this
research by assessing healthcare providers attitudes and decision-making towards older adults
and older adults with SMI. The results of the present study indicate that providers expected the
patient with SMI to be less competent and were less likely to recommend they receive a referral
for a sleep study compared to patients without SMI. Additionally, providers expected the older
adult patient to have more difficulty reading and understanding educational material compared to
the younger adult patient.
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INFLUENCE ON PROVIDERS’ DECISION MAKING
Introduction
Stigma is a complex issue that often impacts individuals with mental illness. While
stigma is often conceptualized inconsistently in the literature, several key terms are generally
accepted (Fox et al., 2018; Link & Phelan, 2001): stereotypes (cognitions), prejudice (affect),
and discrimination (behaviors). Applying these terms to mental illness, stereotypes are the beliefs
about people with mental illness, such as that they are incompetent or dangerous. Prejudice is the
emotion that people have towards those with mental illness, and discrimination is unfair
treatment of people with mental illness that results in their being at a disadvantage. Each
individual may experience stigma differently based upon personal factors, including gender,
ethnicity, socioeconomic status, age, etc., and how these factors interact. For instance, a 72-yearold Black woman may experience stigma of mental illness differently than an 18-year-old White
male. These contextual differences may impact how individuals are affected by stigma.
While stigma affects a multitude of populations, this study focuses on the populations of
individuals with serious mental illness (SMI) and older adults. Both of these populations are
especially vulnerable to stigma due to their increased risk of cognitive deficits, somatic
conditions, and increased need for healthcare (Alzheimer's Association, 2016; Centers for
Disease Control and Prevention, 2017; De Hert et al., 2011; Viron & Stern, 2010; Young et al.,
2016). Although there is an abundance of literature regarding the stigma experienced by those
with SMI and the stigma experienced by older adults, these two populations are rarely examined
together. Given that individuals with SMI make up a small percentage of the general population
(4-6.8% globally; Kessler et al., 2009), and an even smaller percentage of older adults (2.7% of
adults over 50; Substance Abuse and Mental Health Services Administration, 2018), this lack of
literature is understandable. However, as people become more likely to live to age 65 and
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beyond, more individuals with SMI will also reach old age (Meesters et al., 2012), with this
population expected to grow to over one million people by 2028 (Cohen et al., 2008). While a
small part of the overall population, both older adults and individuals with SMI frequently access
healthcare due to higher health needs and thus make up a large portion of healthcare costs
(Centers for Disease Control and Prevention, 2014; De Hert et al., 2011). Stigma from healthcare
providers can serve as a barrier to seeking and remaining in treatment as well as contribute to
inequality in the frequency and quality of treatment these populations receive (Kisely et al.,
2009; Xiong et al., 2008). The following sections provide a literature review of stigma in SMI
and older adults and reviews a study that assessed providers’ stigmatizing expectations of these
populations.
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Review of the Literature
Serious Mental Illness
SMI is a broad term used to refer to individuals diagnosed with schizophrenia,
schizoaffective, bipolar disorder, and major depressive disorder (De Hert et al., 2011) and has a
prevalence rate of 4-6.8% globally (Kessler et al., 2009). The stigma experienced by individuals
with SMI is associated with discrimination in several areas, including employment, housing, and
interactions with law enforcement (Corrigan et al., 2003; Stuart, 2006) because people with SMI
are often stereotyped as incompetent or dangerous (Corrigan & Shapiro, 2010).
Face-to-face interviews of individuals diagnosed with schizophrenia found that almost half felt
discrimination in making friends and from family members, 29% felt discrimination in finding
and keeping a job, and 72% said they felt the need to conceal their diagnosis (Thornicroft et al.,
2009). Another survey of the general public found high amounts of stereotypes and prejudice
against those with SMI, as only 51% of people believed individuals with SMI could work in
regular jobs, 77% would not consider marrying someone with SMI, and 42% would be disturbed
sharing a room with someone with SMI (Gaebel et al., 2002). These perceptions can lead to
significant discrimination, such as individuals with SMI being less likely to receive an interview
for a job than someone with a physical illness (Hipes et al., 2016). It is possible that these
stereotypes and prejudice directly contribute to individuals with SMI having fewer financial
resources and fewer social supports, as they represent approximately a quarter of the homeless
population (Cortes et al., 2011). Stigma also impacts care partners of those with SMI, with
stigma related experiences often being salient, associated with increased distress, difficulty
coping, and inversely related to general family functioning (Muralidharan et al., 2016). This
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impact demonstrates how stigma does not only affect the individual with the diagnosis but also
carries additional cost to other people in their life.
Stigma in Healthcare
Stigma also exists within healthcare and can serve as a significant barrier to accessing
services. Many individuals who have SMI may not seek services because receiving a diagnosis
could subject them to being stigmatized by others and negatively impact their self-esteem
(Corrigan, 2004). People with SMI may have also been stigmatized in a healthcare setting in the
past and be less likely to return when a new somatic or mental health need arises (Corrigan et al.,
2009; Lawrie et al., 1996; Mak et al., 2007; Thornicroft et al., 2007). This avoidance is
understandable as experiencing stigma is associated with a multitude of psychological effects,
such as elevated depression (Ritsher & Phelan, 2004), reduced levels of self-esteem, lower
quality of life, less social support, and greater psychiatric symptom severity (Livingston & Boyd,
2010; Lysaker et al., 2006).
If individuals with SMI do access healthcare, they may be stigmatized by healthcare
providers as providers may perceive them as difficult or attention-seeking and misattribute their
physical symptoms to their mental health disorder (Thornicroft et al., 2007). A review by Mak
and colleagues (2007) found that nurses frequently feel fear, hostility, and blame towards people
with mental illness, believing they were not truly sick and were less deserving of their time. They
also found that general medical nurses often devalued the mental health aspect of their patients
as they believed it was not their responsibility to address mental health concerns. Primary care
physicians are also affected, as they are more likely to view people with mental illness as
incompetent, not adherent to treatment, and violent (Lawrie et al., 1996; Sullivan et al., 2015).
The stereotypes, prejudice, and discrimination discussed above exist not only in primary care
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settings, but also in mental health settings. For instance, mental health professionals are just as
likely as the general public to view people with mental illness as dangerous and psychiatrists are
more likely than other providers, or even the general public, to endorse stigma of individuals
with mental health disorders (Nordt et al., 2006). In general, mental health providers hold
stigmatizing attitudes towards people with mental illness, expecting them to have more negative
traits than the general public, seeing them as more unpredictable, weird, threatening, and
dangerous (Lauber et al., 2006; Wahl & Aroesty-Cohen, 2010). It is important to acknowledge
that mental health providers themselves may be a barrier to people with SMI accessing care as
when people with SMI experience stigma from healthcare providers (including mental health
providers) they are less likely to seek treatment (Clement et al., 2015; Thornicroft, 2008) or
remain in treatment (Smith et al., 2013).
If people with SMI experience stigma from providers, who they may see as authority
figures and experts, they may believe these stereotypes to be true for themselves. For instance, a
provider may express concern to someone with SMI that they are not competent to make their
own treatment decisions because of their diagnosis. That individual may then consider
themselves incompetent and experience the “why-try” effect (Corrigan et al., 2009), where they
may avoid participating in treatment as they believe it will not be useful for them or see
themselves as not competent enough to fully participate. Alternatively, the person with SMI may
be offended that they are perceived as incompetent and may discontinue treatment. This pattern
of experiencing stigma from healthcare providers disproportionately affects this population, as
individuals with SMI report more negative interactions with providers and experience stigma
more often than those with less severe psychopathologies and frequently identify these
experiences as barriers to initiating and continuing treatment (Mojtabai et al., 2011). Due to these
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negative interactions, people with SMI may hide their diagnosis or avoid seeking healthcare
services altogether (Clement et al., 2015). In contrast, other people with SMI may feel that they
need to exaggerate their symptoms in order to receive the care that they need (Lester et al.,
2005), likely expecting their symptoms to be dismissed or not taken seriously by providers.
These findings of stigma as a barrier for people with SMI are also consistent with previous
research in other populations, as stigma has been found to be a barrier to help-seeking for mental
healthcare in veterans (Pietrzak et al., 2009), young people (Gulliver et al., 2010), and ethnic
minorities (Clement et al., 2015).
Given that stigma can serve as a barrier to initiating and remaining in treatment, it is
possible that stigma may contribute to people with SMI experiencing inequalities in the amount
and quality of health services they receive. For example, in 2016 approximately one third of
people with SMI did not receive mental health services (Park-lee & Tice, 2017). Individuals with
SMI also experience inequalities in treatment for somatic issues, including lower quality care in
treatment after stroke (Kisely et al., 2009), being less likely to receive cancer screenings (Xiong
et al., 2008), and receive adequate care for cardiovascular disease (Laursen et al., 2009). These
inequalities in healthcare are especially relevant to individuals with SMI given their increased
risk of a multitude of somatic conditions, including diabetes, cardiovascular disease, obesity,
cancer, respiratory tract diseases, musculoskeletal diseases, sexual dysfunctions, pregnancy
complications, stomatognathic diseases, and metabolic syndrome (De Hert et al., 2011).
Cardiovascular disease is of special concern as it is 2-3 times more prevalent in individuals with
SMI and also the most common cause of death in this population. Metabolic syndrome is also a
significant issue for this population, as it is characterized by obesity, elevated blood pressure,
dyslipidemia, and impaired glucose metabolism or insulin resistance (Li & Ford, 2006); is
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prevalent (32.6%) in individuals with SMI (Vancampfort et al., 2015); and is associated with use
of antipsychotic medications which are regularly used to treat SMI (Hasnain et al., 2010). While
the effects of stigma have been shown for individuals with SMI, pervasive and impactful effects
of stigma can also be seen in other populations, including older adults.
Older Adults
The label “older adult” is a general term often used to refer to individuals over 65. The
stigma often experienced by older adults is called ageism and is commonly seen as older adults
being viewed as senile, old-fashioned, incompetent, or unattractive (Butler, 1975; Iversen et al.,
2009). Some research indicates that ageism can have negative effects on the functioning of older
adults. One longitudinal study of 395 individuals assessed the effect of negative age stereotypes
(e.g., old people are absent minded, old people cannot concentrate well) on memory over 38
years (Levy et al., 2012). Participants were assessed on how much they believed negative age
stereotypes and also received memory assessments multiple times throughout the study. At the
end of the longitudinal study the researchers discovered that individuals who endorsed more
negative age stereotypes had a 30% worse decline in memory as they aged than those who
endorsed fewer negative age stereotypes. Similar effects of negative age stereotypes have also
been found in regard to older adults’ abilities to participate in activities of daily living, such as
eating, bathing, or dressing (Moser et al., 2011). While broad and firm conclusions on the
specific effects of stigma should not be made from two studies, these results raise concern
regarding the impact of stigma on older adults.
Ageism may also lead older adults to experience discrimination in several areas of their
life. For instance, a study by Rupp and colleagues (2006) found that older adults are more likely
to receive more severe recommendations for poor performance at their jobs, such as requests for
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resignations or demotions, and are less likely to receive formal assistance for performance
problems. Younger workers were 40% more likely to receive interviews than older adults
(Lahey, 2005), and older adults were 41% less likely to be accepted for a job position than an
equally qualified younger worker (Bendick et al., 1999).
Stigma in Healthcare
Older adults may also experience stigma within healthcare. Surveys of older adults
indicate that approximately one out of five older report having experienced at least one instance
of healthcare discrimination (Rogers et al., 2015). Those who endorsed having experienced
discrimination were most likely to believe their age to be the reason for this discrimination.
Additionally, older adults who said they had experienced discrimination were more likely to
report difficulties with activities of daily living, such as toileting, eating, or dressing. Individuals
over 65-years-old also experience discrimination in research as they are not adequately
represented in, and are often excluded from, clinical trials (Cherubini et al., 2010). This creates a
significant lack of data on the use of medications and interventions in older adults, leading to the
use of these medications and interventions for older adults to be based on extrapolations from
research on younger populations. This mismatch between research and practice leads to
interventions being used for older adults with little knowledge regarding their potential outcomes
or side effects for this population. The quality of care is also lower in a multitude of areas for
older adults. A study done by Steel and colleagues (2008) surveyed almost 8,700 older adults
assessing indicators of quality care (e.g., all diabetic persons aged 50 or above should have an
annual examination of their feet) for 13 different disorders, including diabetes, fall management,
and depression. If an older adult reported a health condition, they were also asked if they had
received indicated care based on established guidelines from the healthcare provider. Based on
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self-report measures, their results indicated that older adults who reported a general medical
condition (e.g., cardiovascular disease, depression, hypertension) said that they received
indicated care approximately 75% of the time. In contrast, older adults who reported a geriatric
condition (e.g., urinary incontinence, falls management, osteoporosis) said that they received
indicated care approximately 55% of the time. It is possible that this difference may reflect
discrimination from healthcare providers, who may see problems more common with older
adults as less important.
The effects of ageism, specifically in healthcare, are especially impactful for older adults
given the somatic conditions and cognitive deficits they can experience. One of the more
prevalent and impactful conditions in older adults is dementia. While multiple subtypes of
dementia exist, the most common type is Alzheimer’s disease, a degenerative brain disease,
which accounts for 60-80% of all cases and is also the fifth leading cause of death in older adults
(Alzheimer’s Association, 2016). Of the estimated 5.3 million people in the USA who have
Alzheimer’s disease, 5.1 million of them are over 65. Older adults are also significantly affected
by diabetes, with over 25% of individuals 65 and older in the USA being diagnosed with
diabetes (Centers for Disease Control and Prevention, 2014) and approximately 71% of deaths in
individuals over 70 being attributed to diabetes (American Diabetes Association, 2013). Older
adults with diabetes are also significant utilizers of healthcare, accounting for 59% of direct and
88% of indirect (e.g., permanent disability, premature mortality) medical costs for diabetes
(American Diabetes Association, 2013). Due to the significant effects of stigma for people with
SMI and older adults, how stigma of these populations exists in healthcare, as well as a lack of
literature regarding how stigma may affect older adults with SMI, an investigation of these
concerns is warranted.
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The Present Study
The present study expands the literature on the impact of stigma in regard to SMI and
older adults, specifically within the area of healthcare, having explored healthcare provider
stigma against these populations. This was accomplished by using the materials, specifically the
vignette and the survey, of Sullivan and colleagues (2015). Sullivan and colleagues (2015)
conducted a study where they had 275 healthcare providers (working in either primary care or
mental health) from five different Veterans Affairs facilities examine one of two vignettes and
complete a survey. The survey asked questions about the individual in the vignette in regard to
expected treatment adherence, ability to read and understand educational material, competence to
manage treatment decisions and money, and the likelihood the healthcare provider would refer
this individual to specialized services (weight loss, pain management, or a sleep study). Both
vignettes were identical in that they represented a high-functioning individual (stable
employment, living in the community, socially active, no current symptoms), with the exception
that in one the individual had a history of schizophrenia and the other did not. Their results
indicated providers having more stigmatizing attitudes towards individuals with SMI, having
statistically significant differences for adherence, ability to read and comprehend the educational
materials, referral to weight reduction programs, and competence. Sullivan and colleagues also
discovered that responses to vignette types were not affected by whether the respondents worked
in primary care or in mental health.
Using materials from Sullivan and colleagues (2015) accomplished several things. First,
replicating their materials allowed for consistency in materials across studies. Second, this study
extended the use of their materials to include older adults and older adults with SMI. This
extension on their materials grows the literature on how stigma affects older adults and is one of
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the few studies examining how stigma affects older adults with SMI. Lastly, this study was
conducted with healthcare providers outside of the VA. Given that the VA is a unique healthcare
system within the U.S., this study allows for comparisons to healthcare providers in other
systems.
Healthcare providers were sent vignettes describing a high-functioning individual who
has stable employment, is psychiatrically stable, and regularly engages in social activities. Each
vignette was identical except some vignettes identified that this person has schizophrenia, some
vignettes identified the person as an older adult, others identified this person as an older adult
with schizophrenia, and some identified the individual as a middle-aged person with no
diagnosis. These vignettes were accompanied by a survey which assessed healthcare providers
stigmatizing attitudes towards people with SMI and older adults, in regard to expected treatment
adherence, ability to read and comprehend educational materials, and competence to handle
health and personal affairs, as well as their likelihood to refer them to specialized services. The
healthcare providers surveyed included clinical social workers, registered nurses (RNs),
psychologists, psychiatrists, and primary care providers (including nurse practitioners, physician
assistants, physicians), and were separated by whether their area of practice was primary care or
mental health. Separating providers by area of practice will provide evidence for if providers
express more stigmatizing attitudes based on where they are employed. This information can
help inform interventions on stigma by identifying if specific areas of practice should be
prioritized. The hypotheses for this study were as follows:
1. Healthcare providers presented with a vignette of an older adult or person with SMI will
endorse more stigmatizing attitudes and be less likely to recommend referrals than
healthcare providers presented a vignette of a person under 65-years-old without SMI.
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2. Healthcare providers will endorse more stigmatizing attitudes and be less likely to
recommend referrals when presented a vignette of an older adult with SMI than when
presented with any other of the vignettes.
3. Healthcare providers whose area of practice is primary care will endorse more
stigmatizing attitudes and be less likely to recommend referrals than healthcare providers
whose area of practice is mental health when presented with any vignette of a person with
SMI or an older adult.
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Methods
Participants
Participants (n = 144) were clinical and medical social workers (n = 13), registered nurses
(n = 54), psychologists (n = 43), psychiatrists (n = 6), nurse practitioners (n = 5), physician
assistants (n = 5), physicians (n = 12), and other provider types (n = 6; e.g., counselor,
pharmacist). Participants were excluded if they were not a healthcare provider (e.g., student,
chaplain). Based on a power analysis, 12 participants were required for each of the four vignette
groups; however, 15 participants were used to allow for more conservative analyses. As each
vignette type was also divided into mental health providers and primary care providers, a total of
eight groups were created, requiring a minimum of 120 participants.
Measures
Demographic form
All participants completed a short demographics form near the end of the survey. This
collected information on the participant’s healthcare discipline (e.g., nurse, psychiatrist), gender,
age, race, and years in clinical practice. Information on participant’s area of practice was also
collected by asking the participant to identify whether they worked within primary care or mental
health.
Provider stigma measure
As there was a lack of established scales, Sullivan and colleagues (2015) created their
own measure for their study by developing focus groups composed of individuals with SMI,
family members of patients, psychiatrists, mental health nurses, primary care nurses, and primary
care physicians. Focus groups identified provider expectations which they believed could be
influenced by a diagnosis of mental illness, specifically adherence, understanding educational
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materials, competence, and common scenarios in care situations where the patient may or may
not have schizophrenia. Sullivan and colleagues then developed 27 questions based on specific
issues that the focus groups had raised and included three single questions on whether a provider
would refer the patient to specialized services. After conducting a factor analysis, they created
three separate factors for adherence (three items), ability to read and understand educational
material (four items), and competence (three items). The researchers also included the three
items which assess the likelihood that provider would recommend a referral for this patient to
services for weight reduction, pain management, and sleep studies. Each item, with the
exception of competence, was created on a scale of 1-10 ranging from not likely at all to
extremely likely with higher scores indicated higher expectations of the patient. Items measuring
competence were on a scale of 1-4, ranging from not able at all to very able, with higher scores
indicating greater expected competence.
Other Measures
Other stigma measures were included in the survey to allow for potential replication of
other studies. These measures included the Characteristic Scale, the Attribution Questionnaire,
Social Distance Scale, Bar-On EQ, Jefferson Scale of Physician Empathy, Authoritarianism
Scale, Allocation of Resources, The National Comorbidity Survey, and the Level of Familiarity
Scale. These measures were presented in a random order for each participant compared to the
primary study materials to randomize missing data.
Study Design and Procedure
This study partially replicated Sullivan and colleagues (2015), primarily by the use of
their vignette and survey, though some methods were significantly changed. That study was part
of a larger study that resulted in several other publications on healthcare providers and stigma
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(Corrigan et al., 2014; Mittal et al., 2014; Smith et al., 2017). While participants in this study
were presented with the entire original survey, for the purposes of this study we analyzed the
survey questions examined by Sullivan and colleagues (2017) covering expected ability to read
and understand educational material, competence, adherence, and likelihood of recommendation
for a referral for weight management, pain management, or sleep.
Some minor changes to the original survey were also included. Surveys were completed
through Qualtrics, an online survey platform (Appendix A). As an incentive to complete the
survey, participants had the opportunity to be entered into a drawing to win one of four $50 gift
cards. The question on gender included a selection for self-identification. Additionally, a
question inquiring if the participant worked at the VA was removed from the demographics
section because the VA was not surveyed. A small specification was added to the older adult
vignette noting that they have normal renal functioning to reflect appropriate use of naproxen in
the vignette. A response was also added for the referral questions that this question was not
applicable to that provider’s role. This was added given the variety of healthcare providers being
surveyed who may feel it inappropriate given their role to recommend a referral. Three questions
were also added to provide a more comprehensive assessment of provider’s expected
competence of patient in the vignette. All providers were also asked to report via three additional
items what percentage of individuals with schizophrenia they believed were competent to make
their own decisions, to read at a sixth-grade level, and are adherent to treatment. All providers
were asked these same questions in regard to older adults. This study received approval from the
institutional review board at Eastern Michigan University (Appendix B).
Procedure
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To conduct the present study, a link to the survey on Qualtrics was sent to healthcare
providers via email which provided providers with a general description of the purpose of the
survey, that participation was anonymous and voluntary, and asked if they were willing to
consent to participate in the study. Participants were then provided with the vignette and survey
questions. Each participant received one of the four versions of the vignette (Appendix C),
although which version of the vignette they receive was randomized. Upon completion of these
questions the participants were directed to a screen thanking them for completing the survey and
providing them a link where they had the option to enter their email for a chance to win a $50
Amazon gift card.
Online searches of providers as well as medical and mental health clinics were used to
identify eligible participants. Searches included professional organizations (e.g., Michigan
Nurses Association) and facilities (e.g., hospitals, community mental health, inpatient
psychiatry). Emails were sent to 267 eligible facilities and providers providing a description of
the study, a link to the vignette and survey, and encouraging the recipient to distribute the survey
to other providers (Appendix D).
Data Analysis
To test Hypotheses 1 and 2, a series of 2 (age) X 2 (SMI) general linear regression
models were used to evaluate the main effects and possible interaction between patient age
(younger, older) and SMI (no, yes) for each of the outcome variables (Appendix E). None of the
possible interaction effects were statistically significant for these analyses; therefore, only main
effects are reported. Testing Hypothesis 3, provider area of practice (primary care, mental health)
was added to the ANOVA model to test for possible interactions with age and SMI. Given
sample size limitations, the three-way interaction between age, SMI, and provider area of
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practice was not tested. None of the possible interaction effects were statistically significant for
these analyses, therefore, only main effects were reported.
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Results
One-hundred and forty-four healthcare providers participated in the study. Providers were
generally young, White, and female (Table 1). More providers in the sample reported their area
of practice as mental health than primary care. Participants were well distributed between
conditions, though the combined vignette had more participants compared to the other
conditions. Given the homogeneity of race and gender in the sample, these covariates were not
included in the analyses. Additionally, as years of practice was not correlated with any dependent
variables, and age only slightly correlated with sleep referral (Table 2), these covariates were
also not included in the analyses. There was some missing data due to participants not
completing the survey (maximum single variable missingness; n = 11) and list-wise deletion was
used for missing data in provider type (n = 3). Results of the Shapiro-Wilkes test indicated that
data violated the normality assumption (p < .001) for competence, with skewness of -1.44.
Based on the Shapiro-Wilkes test, the normality assumption was also violated for the model
predicting sleep referral (p < .001), with skewness of .76. Bootstrap resampling was used for
competence and sleep referral models. As results did not change for either model (both models
were statistically significant) raw data was used. The assumption of homogeneity, F(1, 98) =
3.08, p < .05, was also violated for vignette type for the competence variable. General linear
regression models were used to evaluate the main effects between patient age (younger, older)
and SMI (no, yes) for each of the 6 outcome variables. The omnibus F-tests for the linear
models predicting adherence, weight referral, and pain referral, from patient age and patient SMI
status were not statistically significant (Table 3). There were significant main effects for
competence, ability to read and understand educational material, and sleep referral. Welch’s F
was applied to the competency model as it does not assume homogeneity of variance between
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groups, F(3, 74.80) = 4.01, p < .05. Statistical significance of this test indicates that responses of
expected competency did differ between different vignette groups. Specifically, compared to
individuals without SMI, providers expected individuals with SMI to be less competent and
providers were less likely to make a referral for a sleep study. Additionally, providers expected
older adults to be to be less able to read and understand educational material compared to
younger adults.
Table 1
Demographics
Variable

% (n)

Gender
Female

80.5% (n = 116)

Male

17.3% (n = 25)

Other

1.3% (n = 2)

Age
Less than 30

31.2% (n = 45)

Between 31-40

28.5% (n = 41)

Between 41-50

12.5% (n = 18)

Between 51-60

15.3% (n = 22)

Over 61

11.8% (n = 17)

Race
White

88.9% (n = 128)

Non-White

11.1% (n = 16)
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Table 1 continued
Demographics
Variable

% (n)

Condition
Comparison

22.2% (n = 32)

SMI

25.0% (n = 36)

Older adult

21.5% (n = 31)

Combined

31.3% (n = 45)

Area of Practice
Primary care

43.1% (n = 62)

Mental health

56.9% (n = 82)

For Hypothesis 3, provider area of practice was added to the model (Table 4).
The main effects general linear regression model predicting adherence, F(3, 140) = 2.12, p = .10,
R2 = .02, ability to read and understand educational material, F(3, 140) = 2.66, p = .05, R2 = .03,
weight referral, F(3, 12d 19) = 2.61, p = .05, R2 = .04, pain referral, F(4, 129) = 2.11, p = .08, R2
= .03, and sleep referral, F(3, 130) = 2.16, p = .09, R2 = .03, from patient age, patient SMI status,
and provider area of practice, were not statistically significant. While the model predicting
competence was statistically significant, F(3, 137) = 3.47, p < .05, R2 = .05, the only significant
difference, as previously reported, was for the SMI condition.

INFLUENCE ON PROVIDERS’ DECISION MAKING

21

Table 2
Means, Standard Deviations, and Correlations With Confidence Intervals
Variable

M

SD

1

2

1. Competence

3.42

0.53

2. Adherence

6.14

1.76

.49**
[.36, .61]

3. Ability to read
and understand
educational
material

5.86

2.02

.43**

.42**

[.28, .55]

[.27, .55]

3

4

5

6

4. Weight referral

5.59

3.07

.15
[-.02, .31]

.04
[-.13, .21]

.22**
[.06, .38]

5. Pain referral

6.81

2.56

.03
[-.14, .20]

.01
[-.16, .18]

.08
[-.09, .25]

.23**
[.06, .39]

6. Sleep referral

5.10

2.96

.03
[-.14, .20]

-.02
[-.19, .15]

.10
[-.07, .26]

.52**
[.38, .63]

.18*
[.01, .34]

7. Age

2.48

1.38

.03
[-.14, .20]

.06
[-.10, .22]

-.00
[-.17, .16]

.08
[-.09, .25]

.06
[-.11, .23]

.17*
[.00, .33]

12.37

13.33

-.05
[-.21, .12]

.02
[-.15, .19]

-.05
[-.22, .11]

.03
[-.14, .21]

.04
[-.14, .21]

.12
[-.05, .29]

8. Years in practice

Note. Values in square brackets indicate the 95% confidence interval for each correlation. * p < .05. ** p < .01

7

.83**
[.77, .87]
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Table 3
Main Effects Between Patient Age and SMI For Each of the Outcome Variables
Patient age
younger
Variable

M (SD)

Patient SMI status

older

no

yes

M (SD)

M (SD)

M (SD)

df

F

p

adj. R2

Adherence

6.24 (1.68)

6.06 (1.84)

6.37 (1.69)

5.96 (1.81)

2, 141

1.08

.342

.00

Competence

3.47 (.51)

3.38 (.55)

3.57a (.45)

3.31a (.57)

2, 138

4.01

.029

.05

Education

6.29b (1.93)

5.48b (2.04)

6.01 (1.96)

5.75 (2.07)

2, 141

3.13

.047

.03

Weight referral

5.55 (3.09)

5.63 (3.07)

6.22 (3.00)

5.11 (3.04)

2, 130

2.25

.109

.02

Pain referral

6.57 (2.74)

7.04 (2.37)

6.78 (2.82)

6.84 (2.35)

3, 131

.57

.565

.00

Sleep referral

5.28 (2.98)

4.93 (2.95)

5.80c (2.96)

4.55c (2.86)

2, 131

3.22

.043

.04

Note. a p < .01. b p < .05. c p < .05. All F-test results are from the models evaluating the main effects between patient age (younger,
older) and SMI (no, yes) for each of the 6 outcome variables. Results from the model testing Hypothesis 3 predicting the dependent
variables from patient age, SMI status, and provider area of practice are not presented in this table as no results were statistically
significant.
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Table 4
Main Effects For Provider Area of Practice For Each of the Outcome Variables
Primary

Mental

M (SD)

M (SD)

Adherence

5.81 (1.75)

6.39 (1.74)

Competence

3.37 (.53)

3.47 (.53)

Education

5.58 (2.04)

6.07 (2.00)

Weight referral

5.15 (2.92)

6.19 (3.16)

Pain referral

6.47 (2.87)

7.08 (2.28)

Sleep referral

5.22 (3.10)

5.00 (2.87)

Variable
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Discussion
The hypothesis that healthcare providers presented with a vignette of an older adult or
person with SMI would endorse more stigmatizing attitudes and be less likely to provide
referrals than healthcare providers presented a vignette of a person under 65-years-old without
SMI was partially supported. Providers expected individuals with SMI to be less competent and
were less likely to provide them with referrals for a sleep study compared to patients without
SMI. Additionally, providers expected older adults to have less ability to read educational
material compared to younger adult patients. It is possible that these differences in provider
attitudes may not reflect stigma. In fact, these provider expectations have the potential to be a
benefit to the patient, as providers may then spend more time with these patients to ensure that
they understand the information and material presented to them. Alternatively, these differences
in expectations may reflect stereotypes and lead to discrimination, potentially leading providers
to overly simplify their language, slow their rate of speech, and alter their intonation in an
attempt to communicate more clearly. However, communicating in this manner is typically
disrespectful and patronizing and can be very offensive to the patient. When older adults
experience this type of communication from providers (i.e., elderspeak) it is associated with a
breakdown in communication and a disruption of care (Williams et al., 2009; Williams et al.,
2016). Poor provider communication can have significant impacts on treatment adherence, as
there is a 19% greater risk of nonadherence to treatment among patients whose provider
communicates poorly (Zolnierek & DiMatteo, 2009). The decreased likelihood of referral for a
sleep study for individuals with SMI could represent providers seeing these patients’ complaints
of sleep to be related to their mental health diagnosis (Thornicroft et al., 2007). Alternatively,
providers may see prescribing an antipsychotic for the diagnosis of SMI to be sufficient for
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resolving issues with sleep as antipsychotics can have tranquilizing effects. To confirm if these
differences in attitudes reflect provider stigma, future research should determine if providers
behavior is affected by these attitudes (e.g., are lower expectations of ability to read educational
related to elderspeak).
The second hypothesis that healthcare providers would endorse more stigmatizing
attitudes and be less likely to provide referrals when presented a vignette of an older adult with
SMI than when presented with any other of the vignettes was not supported. This result
indicates that the stigma of individuals with SMI and ageism was not additive.
The final hypothesis that healthcare providers whose area of practice was primary care
would endorse more stigmatizing attitudes and be less likely to recommend referrals than
healthcare providers whose area of practice is in a mental health setting when presented with any
vignette of a person with SMI or an older adult was not supported.
There are several limitations to this study. An important limitation, as well as the
Sullivan and colleagues’ study, is that stigma was measured by assessing providers’ attitudes and
expectations of patients, not the providers’ actual behavior. No firm conclusions can be made on
how providers’ reported attitude and expectations will impact their behavior. Given the results
of this study, future research should determine whether providers interact with older adults and
older adults with SMI in a more stigmatizing way, specifically when providing and discussing
educational materials. Another important limitation to this study is that provider likelihood of
recommending a referral could have been influenced by their role. For example, nurses may
have reported a lower likelihood of recommending a referral due to feeling this was outside of
their scope of practice rather than due to stigmatizing attitudes. While providers were allowed to
answer that this question was not applicable to their role, it is still possible the questions on
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referrals were not assessing provider stigma. Another limitation is that this study was conducted
using an online survey, so it is impossible to verify that the participant was in fact a healthcare
provider. Also, as the survey was distributed to healthcare providers identified by online web
searches, sampling of participants was not random and may be biased to region, so providers
who participated in the study also may not be a representative sample of providers in the general
workforce. Additionally, as participants did not complete the survey in person, they may have
been less likely to remain fully engaged throughout the entire survey as they could be easily
distracted by other responsibilities
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Conclusion
The results of the present study indicate that providers expected the patient with SMI to
be less competent and were less likely to recommend they receive a referral for a sleep study
compared to patients without SMI. Additionally, providers expected the older adult patient to
have more difficulty reading and understanding educational material compared to the younger
adult patient. Furthermore, providers generally reported similar attitudes regardless of their area
of practice. The result of providers expecting their patients with SMI to be less competent and
older adult patients to have more difficulty reading and understanding educational material could
lead them to spend more time discussing information and materials or make an effort to
communicate more clearly. Alternatively, it could be related to provider stigma and indicate an
association between these expectation and poor communication (i.e., elderspeak) with these
populations. Further research is needed to determine how this provider expectation would
impact their behavior with these populations.
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Appendix A: Qualtrics Survey

Start of Block: Intro Block
Q1 Consent Form Project Title: Understanding Provider Decision MakingPrincipal
Investigator: Michael Vriesman, Graduate StudentFaculty Advisor: Dr. Alexandros Maragakis,
Assistant Professor of Psychology Purpose: The purpose of this research study is to better
understand how providers make decisions about their patients’ care. Study
Procedures: Participation in this study involves completing an online survey. It should take
between 7 and 15 minutes to complete the survey. Data will be collected from participants about
a fictional patient to better understand providers’ decision making. Demographic information
will also be gathered on participants, including provider discipline, gender, and racial
background. Risks: The primary risk of participation in this study is a potential loss of
confidentiality. Some of the survey questions are personal in nature and may make you feel
uncomfortable. You do not have to answer any questions that make you uncomfortable or that
you do not want to answer. Benefits: Participants will not directly benefit from participation.
Benefits to society include understanding factors that influence provider decision
making. Confidentiality: We will keep your information confidential on the online survey
platform Qualtrics behind high-end firewall systems. When data is extracted from Qualtrics it
will be transferred to a password protected computer and all data files will be password
protected. All data will be stored for an indefinite amount of time. We will not ask for your
name and your responses will not be connected to your email address if you choose to enter for a
chance to win a $50 Amazon gift card. After we determine the winners of the gift cards your
email address will be deleted and there will be no record of your participation in this study. The
results of this research may be published or used for teaching. Identifiable information will not
be used for these purposes. Compensation: You will have a chance to win an Amazon gift card
for $50 for participating in this research study. You may enter your email address at the end of
the survey so that if you are selected we can send you an electronic gift card that you can print
and use. Contact Information: If you have any questions about the research, you can contact
the Principal Investigator, Michael Vriesman at mvriesm1@emich.edu or by phone at 231-4500094. You can also contact Michael’s adviser, Dr. Alexandros Maragakis, at
amaragak@emich.edu or by phone at 734-487-2147. For questions about your rights as a
research subject, you can contact the Eastern Michigan University Office of Research
Compliance at human.subjects@emich.edu or by phone at 734-487-3090. Voluntary
participation Participation in this research study is your choice. You may refuse to participate at
any time, even after starting this survey, with no penalty or loss of benefits to which you are
otherwise entitled. You may choose to leave the study at any time by closing the browser
window with no loss of benefits to which you are otherwise entitled. If you leave the study, the
information you provided will be kept confidential. You may request, in writing, that your
identifiable information be destroyed. However, we cannot destroy any information that has
already been published. Statement of
Consent
I have read this form. I have had an
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opportunity to ask questions and am satisfied with the answers I received. By answering "yes" I
indicate my consent to participate in this research study.

Consent

o Yes (1)
o No (2)
Skip To: End of Survey If = No
End of Block: Intro Block
Start of Block: Comparison Vignette Block
Vingette_A UNDERSTANDING DECISION-MAKING Instructions ·
Please read the
Description of Mr. A. below. ·
Once you have read the Description of Mr. A, assume all
pertinent information has been supplied that you need to answer the questions that follow.
·
Assume you have 30 minutes to see this patient. ·
Assume all resources mentioned in the
questions below are available.
DESCRIPTION OF MR. A
Mr. A is a 34-yearold male with, hypertension, obesity, and chronic low back pain. His X-ray shows evidence of
arthritis. He has been coming to your clinic for about 6 months, and this is his third visit. His
current medications include lisinopril 40 mg daily, naproxen 500 mg twice a day, fluoxetine 20
mg per day. He comes to his appointment today 15 minutes late and states that he has already
used up all of the naproxen for the month in 25 days and would like to have his prescription
filled early or get “something else that works better.” He has tolerated naproxen well. His height
is 5’5” and he weighs 201 lb. Three months ago he weighed 195 lb. His blood pressure today is
150/98, and 3 months ago it was 148/92. Mr. A says that his back pain is “worse than ever” and
that he is having a great deal of trouble sleeping. He looks more disheveled than usual. Mr. A
grew up in a mid-sized city in the northeast United States and completed high school there. He
has no history of substance abuse. He has worked in food services at the VA for 3 years and his
job performance has been above average. He is active in his community and engages in multiple
social activities. Occasionally he goes fishing with his brother.
When answering the following questions, please assume that Mr. A is your patient. Select the
number that best indicates your response. Your “best guess” is fine.
Please
check “N/A” if a question is not applicable to your role.
End of Block: Comparison Vignette Block
Start of Block: Block A - Comparison
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vignA DESCRIPTION OF MR. A Mr. A is a 34-year-old male with, hypertension, obesity, and
chronic low back pain. His X-ray shows evidence of arthritis. He has been coming to your clinic
for about 6 months, and this is his third visit. His current medications include lisinopril 40 mg
daily, naproxen 500 mg twice a day, fluoxetine 20 mg per day. He comes to his appointment
today 15 minutes late and states that he has already used up all of the naproxen for the month in
25 days and would like to have his prescription filled early or get “something else that works
better.” He has tolerated naproxen well. His height is 5’5” and he weighs 201 lb. Three months
ago he weighed 195 lb. His blood pressure today is 150/98, and 3 months ago it was 148/92. Mr.
A says that his back pain is “worse than ever” and that he is having a great deal of trouble
sleeping. He looks more disheveled than usual. Mr. A grew up in a mid-sized city in the
northeast United States and completed high school there. He has no history of substance abuse.
He has worked in food services at the VA for 3 years and his job performance has been above
average. He is active in his community and engages in multiple social activities. Occasionally he
goes fishing with his brother.
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Referral_A How likely, if at all...
Not at
All
Likely
- 1 (1)

2
(2)

3
(3)

4
(4)

5
(5)

6
(6)

7
(7)

8
(8)

9
(9)

Extremely
Likely 10 (10)

N/A
for
my
role
(11)

… would
you be to
recommend
that this
patient be
referred to a
local weight
reduction
program at
this time?
(1)

o

o o o o o o o o o

o

…would
you be to
recommend
that this
patient be
referred to a
local pain
management
program at
this time?
(2)

o

o o o o o o o o o

o

…would
you be to
recommend
that this
patient be
referred to a
sleep study
at this time?
(3)

o

o o o o o o o o o

o
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Adherence_A How likely, if at all...
Not at
All
2 (2) 3 (3)
Likely
- 1 (1)

4 (4)

5 (5)

6 (6)
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7 (7)

8 (8)

9 (9)

Extremely
Likely 10 (10)

…do you
think it is that
this patient
will adhere to
his
medications?
(1)

o

o o o o o o o o

o

…do you
think it is that
this patient
will keep his
regular
appointments?
(2)

o

o o o o o o o o

o

…do you
think Mr. A
will refill his
medications
on time? (3)

o

o o o o o o o o

o

...do you think
Mr. A would
be to read
educational
material you
provide about
hypertension
(written at a
6th grade
level)? (4)

o

o o o o o o o o

o

…do you
think it is that
this patient
would
understand
the written
material about
hypertension?
(5)

o

o o o o o o o o

o
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Prognosis_A How likely, if at all...

44

INFLUENCE ON PROVIDERS’ DECISION MAKING

Not at
All
Likely
- 1 (1)

2 (2)

3 (3)

4 (4)

5 (5)

6 (6)
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7 (7)

8 (8)

9 (9)

Extremely
Likely 10 (10)

…would
you be to
involve this
patient’s
family in his
care or his
treatment
plan? (1)

o

o o o o o o o o

o

…would
you be to
discuss your
concerns
about this
patient with
his brother?
(2)

o

o o o o o o o o

o

...would you
be to ask
Mr. A to
bring his
brother to an
appointment
with you?
(3)

o

o o o o o o o o

o

… do you
think it is
that this
patient’s
hypertension
can be better
controlled
with diet
and
medication?
(4)

o

o o o o o o o o

o
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... do you
think that
Mr. A’s pain
can be
reduced? (5)

o

o o o o o o o o

o

…do you
think this
patient’s
general
health status
will worsen
in the
coming
year? (6)

o

o o o o o o o o

o

…do you
think this
patient is to
advance in
his job? (7)

o

o o o o o o o o

o

…do you
think this
patient
would get
together
socially with
friends or
neighbors
on a regular
basis? (8)

o

o o o o o o o o

o

…do you
think this
patient
would be
able to live
on his own?
(9)

o

o o o o o o o o

o
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VisitTime_A In a 30 minute visit, about how much time would you spend discussing
treatment options with this patient?
________________________________________________________________
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Competence_A In your opinion, how able is...
Somewhat Able
Very Able (4)
(3)
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Somewhat
Unable (2)

Not Able at All
(1)

…Mr. A to make
his own
decisions about
the treatment he
should receive?
(1)

o

o

o

o

…Mr. A to make
his own
decisions about
managing his
own money? (2)

o

o

o

o

...Mr. A to
discuss the
content of items
discussed with
you and to offer
a fairly clear
version of it. (5)

o

o

o

o

...Mr. A to
mention specific
consequences
related to his
treatment
options (6)

o

o

o

o

...Mr. A to state
a treatment
choice, or to
indicate desire
for a
professional or
other responsible
person to make a
treatment choice
for him. (7)

o

o

o

o

…that Mr. A’s
situation will
improve on its
own? (3)

o

o

o

o
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End of Block: Block A - Comparison
Start of Block: Block C - Comparison
Q288 DESCRIPTION OF MR. A Mr. A is a 34-year-old male with, hypertension, obesity, and
chronic low back pain. His X-ray shows evidence of arthritis. He has been coming to your clinic
for about 6 months, and this is his third visit. His current medications include lisinopril 40 mg
daily, naproxen 500 mg twice a day, fluoxetine 20 mg per day. He comes to his appointment
today 15 minutes late and states that he has already used up all of the naproxen for the month in
25 days and would like to have his prescription filled early or get “something else that works
better.” He has tolerated naproxen well. His height is 5’5” and he weighs 201 lb. Three months
ago he weighed 195 lb. His blood pressure today is 150/98, and 3 months ago it was 148/92. Mr.
A says that his back pain is “worse than ever” and that he is having a great deal of trouble
sleeping. He looks more disheveled than usual. Mr. A grew up in a mid-sized city in the
northeast United States and completed high school there. He has no history of substance abuse.
He has worked in food services at the VA for 3 years and his job performance has been above
average. He is active in his community and engages in multiple social activities. Occasionally he
goes fishing with his brother.

Q282 When answering the following questions, assume that Mr. A is your patient. Please select
the number that indicates how much you agree or disagree with the following statements. Your
“best guess” is fine.
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Attitude_A Assuming Mr. A were your patient, how much, if at all, do you agree with the
following statements?
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Not
at All
-1
(1)

2 (2)

3 (3)

4 (4)

5 (5)

6 (6)
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7 (7)

8 (8)

9 (9)

Extremely
Likely 10 (10)

I would
feel pity
for Mr. A.
(1)

o o o o o o o o o

o

I would
think that
it was Mr.
A’s own
fault that
he is in the
present
condition.
(2)

o o o o o o o o o

o

I would
think that
Mr. A is
dangerous.
(3)

o o o o o o o o o

o

I would
think that
Mr. A
should be
forced into
treatment
with his
doctor
even if he
does not
want
treatment.
(4)

o o o o o o o o o

o

I would be
angry with
Mr. A. (5)

o o o o o o o o o

o

I would be
scared of
Mr. A. (6)

o o o o o o o o o

o
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I would
think I can
help Mr.
A. (7)

o o o o o o o o o

o

I would
try to stay
away from
Mr. A. (8)

o o o o o o o o o

o

End of Block: Block C - Comparison
Start of Block: Block B - Comparison
Q289 DESCRIPTION OF MR. A Mr. A is a 34-year-old male with, hypertension, obesity, and
chronic low back pain. His X-ray shows evidence of arthritis. He has been coming to your clinic
for about 6 months, and this is his third visit. His current medications include lisinopril 40 mg
daily, naproxen 500 mg twice a day, fluoxetine 20 mg per day. He comes to his appointment
today 15 minutes late and states that he has already used up all of the naproxen for the month in
25 days and would like to have his prescription filled early or get “something else that works
better.” He has tolerated naproxen well. His height is 5’5” and he weighs 201 lb. Three months
ago he weighed 195 lb. His blood pressure today is 150/98, and 3 months ago it was 148/92. Mr.
A says that his back pain is “worse than ever” and that he is having a great deal of trouble
sleeping. He looks more disheveled than usual. Mr. A grew up in a mid-sized city in the
northeast United States and completed high school there. He has no history of substance abuse.
He has worked in food services at the VA for 3 years and his job performance has been above
average. He is active in his community and engages in multiple social activities. Occasionally he
goes fishing with his brother.

Attribution_A Based on your impression of Mr. A, please select the number that you think best
describes Mr. A’s characteristics along the continuum. Your “best guess” is fine.
1
2
3
4
5
6
7
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1 (1)
Valuable ->
Dirty ->
Insincere ->
Safe ->
Warm - >
Wise ->
Strong ->
Unpredictable
->
Tense ->

o
o
o
o
o
o
o
o
o

2 (2)

3 (3)

o
o
o
o
o
o
o
o
o

o
o
o
o
o
o
o
o
o

4 (4)

o
o
o
o
o
o
o
o
o
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5 (5)

o
o
o
o
o
o
o
o
o

6 (6)

o
o
o
o
o
o
o
o
o

7 (7)

o
o
o
o
o
o
o
o
o

End of Block: Block B - Comparison
Start of Block: Block D - Comparison
Q290 DESCRIPTION OF MR. A Mr. A is a 34-year-old male with, hypertension, obesity, and
chronic low back pain. His X-ray shows evidence of arthritis. He has been coming to your clinic
for about 6 months, and this is his third visit. His current medications include lisinopril 40 mg
daily, naproxen 500 mg twice a day, fluoxetine 20 mg per day. He comes to his appointment
today 15 minutes late and states that he has already used up all of the naproxen for the month in
25 days and would like to have his prescription filled early or get “something else that works
better.” He has tolerated naproxen well. His height is 5’5” and he weighs 201 lb. Three months
ago he weighed 195 lb. His blood pressure today is 150/98, and 3 months ago it was 148/92. Mr.
A says that his back pain is “worse than ever” and that he is having a great deal of trouble
sleeping. He looks more disheveled than usual. Mr. A grew up in a mid-sized city in the
northeast United States and completed high school there. He has no history of substance abuse.
He has worked in food services at the VA for 3 years and his job performance has been above
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average. He is active in his community and engages in multiple social activities. Occasionally he
goes fishing with his brother.

Q285 For the following statements, assume that Mr. A is not your patient, but someone who has
lived in your neighborhood for the past two years. Please select the option that indicates your
response. Your “best guess" is fine.

Social_A Assuming Mr. A was not a patient of yours, how willing would you be to…
Definitely
Probably
Probably
Definitely
Willing (4)
Willing (3)
Unwilling (2)
Unwilling (1)
…move next
door to Mr. A?
(1)

o

o

o

o

…spend an
evening
socializing with
Mr. A? (2)

o

o

o

o

…make friends
with Mr. A? (3)

o

o

o

o

…have Mr. A
start working
closely with you
on a job? (4)

o

o

o

o

…have Mr. A
marry into your
family? (5)

o

o

o

o
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Violence_A In your opinion, how likely is it that...
Somewhat
Very Likely (1)
Likely (2)
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Somewhat
Unlikely (3)

Not Likely at
All (4)

…Mr. A would
do something
violent toward
other people? (1)

o

o

o

o

...Mr. A would
do something
violent toward
himself? (2)

o

o

o

o

End of Block: Block D - Comparison
Start of Block: Block E
Q254 Demographics

Please answer the following questions about yourself.

isFemale Are you.....

o Male (0)
o Female (1)
o Prefer to Self-Describe (2) ________________________________________________
o Prefer Not to Answer (3)
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age How old are you? Are you……
CHECK ONE

o less than 30 years old (1)
o between 31 and 40 years old (2)
o between 41 and 50 years old (3)
o between 51 and 60 years old (4)
o over 60 years old (5)
o Prefer Not to Answer (0)

isLatino Is your background Hispanic or Latino?

o Hispanic or Latino (1)
o Not Hispanic or Latino (0)
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isWhite What is your racial background?
CHECK ALL THAT APPLY

▢ American Indian / Alaska Native (5)
▢ Asian including Southeast Asia (4)
▢ Native Hawaiian or other Pacific Islander (3)
▢ Black or African American (2)
▢ White / Caucasian (1)
▢
Other, Please Specify: (6)
________________________________________________
profess What is your professional discipline?
CHECK ONE

o Clinical Social Worker (1)
o Registered Nurse (2)
o Psychologist (3)
o Psychiatrist (4)
o Nurse Practitioner (5)
o Physician (6)
o Physician's Assistant (7)
o Osteopathic Doctor (8)
o Gerontologist (9)
o Other (please describe) (10) ________________________________________________
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hadTraining Have you received any training or credentialing in psychological or psychiatric
services? If yes, please describe.

o No (0)
o Yes (1) ________________________________________________

gradYear In what year did you graduate from professional school?
________________________________________________________________

pracYear How many years have you been in clinical practice?
________________________________________________________________

specialty Do you work in.....?

CHECK ONE

o Primary Care (0)
o Mental Health (1)
expCompS What percentage of people with schizophrenia do you think are competent to make
their own decisions?
0 10 20 30 40 50 60 70 80 90 100
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Percentage of competent people ()

expEduS What percentage of people with schizophrenia do you think can read at a 6th grade
level?
0 10 20 30 40 50 60 70 80 90 100
Percent at 6th grade reading level ()

expAdhereS What percentage of people with schizophrenia do you think are adherent to
treatment?
0 10 20 30 40 50 60 70 80 90 100
Percentage adherent to treatment ()

expCompO What percentage of older adults do you think are competent to make their own
decisions?
0 10 20 30 40 50 60 70 80 90 100
Percentage of competent people ()

expEduO What percentage of older adults do you think can read at a 6th grade level?
0 10 20 30 40 50 60 70 80 90 100
Percent at 6th grade reading level ()
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expAdhereO What percentage of older adults do you think are adherent to treatment?
0 10 20 30 40 50 60 70 80 90 100
Percentage adherent to treatment ()

End of Block: Block E
Start of Block: Gift Card Block
Q271 Thank you for your time completing this survey. If you would like to be entered for a
chance to win a $50 Amazon gift card please copy and paste the following link onto a different
page and enter in your email address.

https://emichpsych.co1.qualtrics.com/jfe/form/SV_24CN9hnkNnxB7Kt
End of Block: Gift Card Block
Start of Block: Older Adult Vignette Block
Q273 UNDERSTANDING DECISION-MAKING Instructions·
Please read the Description
of Mr. A. below.·
Once you have read the Description of Mr. A, assume all pertinent
information has been supplied that you need to answer the questions that follow.·
Assume you
have 30 minutes to see this patient.·
Assume all resources mentioned in the questions below
are available. DESCRIPTION OF MR. A Mr A is a 60-year-old male with hypertension,
obesity, and chronic low back pain. His X-ray shows evidence of arthritis. He has been coming
to your clinic for about 6 months, and this is his third visit. His current medications include
lisinopril 40 mg daily, naproxen 500 mg twice a day, fluoxetine 20 mg per day. He comes to his
appointment today 15 minutes late and states that he has already used up all of the naproxen for
the month in 25 days and would like to have his prescription filled early or get “something else
that works better.” He has tolerated naproxen well and has normal renal function. His height is
5’5” and he weighs 201 lb. Three months ago he weighed 195 lb. His blood pressure today is
150/98, and 3 months ago it was 148/92. Mr A says that his back pain is “worse than ever” and
that he is having a great deal of trouble sleeping. He looks more disheveled than usual. Mr A
grew up in a mid-sized city in the northeast United States and completed high school there. He
has no history of substance abuse. He has worked in food services at the VA for 3 years and his
job performance has been above average. He is active in his community and engages in multiple
social activities. Occasionally he goes fishing with his brother.
When answering the following questions, please assume that Mr. A is your patient. Select the
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number that best indicates your response. Your “best guess” is fine. Please check “N/A” if a
question is not applicable to your role.
End of Block: Older Adult Vignette Block
Start of Block: Block A - OA
Q307 DESCRIPTION OF MR. A Mr A is a 60-year-old male with hypertension, obesity, and
chronic low back pain. His X-ray shows evidence of arthritis. He has been coming to your clinic
for about 6 months, and this is his third visit. His current medications include lisinopril 40 mg
daily, naproxen 500 mg twice a day, fluoxetine 20 mg per day. He comes to his appointment
today 15 minutes late and states that he has already used up all of the naproxen for the month in
25 days and would like to have his prescription filled early or get “something else that works
better.” He has tolerated naproxen well and has normal renal function. His height is 5’5” and he
weighs 201 lb. Three months ago he weighed 195 lb. His blood pressure today is 150/98, and 3
months ago it was 148/92. Mr A says that his back pain is “worse than ever” and that he is
having a great deal of trouble sleeping. He looks more disheveled than usual. Mr A grew up in a
mid-sized city in the northeast United States and completed high school there. He has no history
of substance abuse. He has worked in food services at the VA for 3 years and his job
performance has been above average. He is active in his community and engages in multiple
social activities. Occasionally he goes fishing with his brother.
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Referral_B How likely, if at all...
Not at
All
Likely
- 1 (1)

2
(2)

3
(3)

4
(4)

5
(5)

6
(6)

7
(7)

8
(8)

9
(9)

Extremely
Likely 10 (10)

N/A
for
my
role
(11)

… would
you be to
recommend
that this
patient be
referred to a
local weight
reduction
program at
this time?
(1)

o

o o o o o o o o o

o

…would
you be to
recommend
that this
patient be
referred to a
local pain
management
program at
this time?
(2)

o

o o o o o o o o o

o

…would
you be to
recommend
that this
patient be
referred to a
sleep study
at this time?
(3)

o

o o o o o o o o o

o
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Adherence_B How likely, if at all...
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Not at
All
Likely
- 1 (1)

2 (2)

3 (3)

4 (4)

5 (5)

6 (6)
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7 (7)

8 (8)

9 (9)

Extremely
Likely 10 (10)

…do you
think it is that
this patient
will adhere to
his
medications?
(1)

o

o o o o o o o o

o

…do you
think it is that
this patient
will keep his
regular
appointments?
(2)

o

o o o o o o o o

o

…do you
think Mr. A
will refill his
medications
on time? (3)

o

o o o o o o o o

o

...do you think
Mr. A would
be to read
educational
material you
provide about
hypertension
(written at a
6th grade
level)? (4)

o

o o o o o o o o

o

…do you
think it is that
this patient
would
understand
the written
material about
hypertension?
(5)

o

o o o o o o o o

o
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…do you
think Mr. A
would be to
read
educational
material you
provide about
nutrition and
diet (written
at a 6th grade
level)? (6)

o

o o o o o o o o

o

…do you
think it is that
this patient
would
understand
the written
material about
nutrition and
diet? (7)

o

o o o o o o o o

o
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Prognosis_B How likely, if at all...
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Not at
All
Likely
- 1 (1)

2 (2)

3 (3)

4 (4)

5 (5)

6 (6)
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7 (7)

8 (8)

9 (9)

Extremely
Likely 10 (10)

…would
you be to
involve this
patient’s
family in his
care or his
treatment
plan? (1)

o

o o o o o o o o

o

…would
you be to
discuss your
concerns
about this
patient with
his brother?
(2)

o

o o o o o o o o

o

...would you
be to ask
Mr. A to
bring his
brother to an
appointment
with you?
(3)

o

o o o o o o o o

o

… do you
think it is
that this
patient’s
hypertension
can be better
controlled
with diet
and
medication?
(4)

o

o o o o o o o o

o
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... do you
think that
Mr. A’s pain
can be
reduced? (5)

o

o o o o o o o o

o

…do you
think this
patient’s
general
health status
will worsen
in the
coming
year? (6)

o

o o o o o o o o

o

…do you
think this
patient is to
advance in
his job? (7)

o

o o o o o o o o

o

…do you
think this
patient
would get
together
socially with
friends or
neighbors
on a regular
basis? (8)

o

o o o o o o o o

o

…do you
think this
patient
would be
able to live
on his own?
(9)

o

o o o o o o o o

o
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VisitTime_B In a 30 minute visit, about how much time would you spend discussing
treatment options with this patient?
________________________________________________________________
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Competence_B In your opinion, how able is...
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Very Able (4)

Somewhat Able
(3)

71

Somewhat
Unable (2)

Not Able at All
(1)

…Mr. A to make
his own
decisions about
the treatment he
should receive?
(1)

o

o

o

o

…Mr. A to make
his own
decisions about
managing his
own money? (2)

o

o

o

o

...Mr. A to
discuss the
content of items
discussed with
you and to offer
a fairly clear
version of it. (5)

o

o

o

o

...Mr. A to
mention specific
consequences
related to his
treatment
options (6)

o

o

o

o

...Mr. A to state
a treatment
choice, or to
indicate desire
for a
professional or
other responsible
person to make a
treatment choice
for him. (7)

o

o

o

o

…that Mr. A’s
situation will
improve on its
own? (3)

o

o

o

o
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…that Mr. A’s
situation will
improve with
treatment? (4)

o

o

72

o

o

End of Block: Block A - OA
Start of Block: Block C - OA
Q313 DESCRIPTION OF MR. A Mr A is a 60-year-old male with hypertension, obesity, and
chronic low back pain. His X-ray shows evidence of arthritis. He has been coming to your clinic
for about 6 months, and this is his third visit. His current medications include lisinopril 40 mg
daily, naproxen 500 mg twice a day, fluoxetine 20 mg per day. He comes to his appointment
today 15 minutes late and states that he has already used up all of the naproxen for the month in
25 days and would like to have his prescription filled early or get “something else that works
better.” He has tolerated naproxen well and has normal renal function. His height is 5’5” and he
weighs 201 lb. Three months ago he weighed 195 lb. His blood pressure today is 150/98, and 3
months ago it was 148/92. Mr A says that his back pain is “worse than ever” and that he is
having a great deal of trouble sleeping. He looks more disheveled than usual. Mr A grew up in a
mid-sized city in the northeast United States and completed high school there. He has no history
of substance abuse. He has worked in food services at the VA for 3 years and his job
performance has been above average. He is active in his community and engages in multiple
social activities. Occasionally he goes fishing with his brother.

Q314 When answering the following questions, assume that Mr. A is your patient. Please select
the number that indicates how much you agree or disagree with the following statements. Your
“best guess” is fine.
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Attitude_B Assuming Mr. A were your patient, how much, if at all, do you agree with the
following statements?
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Not
at All
-1
(1)

2 (2)

3 (3)

4 (4)

5 (5)

6 (6)

74

7 (7)

8 (8)

9 (9)

Extremely
Likely 10 (10)

I would
feel pity
for Mr. A.
(1)

o o o o o o o o o

o

I would
think that
it was Mr.
A’s own
fault that
he is in the
present
condition.
(2)

o o o o o o o o o

o

I would
think that
Mr. A is
dangerous.
(3)

o o o o o o o o o

o

I would
think that
Mr. A
should be
forced into
treatment
with his
doctor
even if he
does not
want
treatment.
(4)

o o o o o o o o o

o

I would be
angry with
Mr. A. (5)

o o o o o o o o o

o

I would be
scared of
Mr. A. (6)

o o o o o o o o o

o
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I would
think I can
help Mr.
A. (7)

o o o o o o o o o

o

I would
try to stay
away from
Mr. A. (8)

o o o o o o o o o

o

End of Block: Block C - OA
Start of Block: Block B - OA
Q316 DESCRIPTION OF MR. A Mr A is a 60-year-old male with hypertension, obesity, and
chronic low back pain. His X-ray shows evidence of arthritis. He has been coming to your clinic
for about 6 months, and this is his third visit. His current medications include lisinopril 40 mg
daily, naproxen 500 mg twice a day, fluoxetine 20 mg per day. He comes to his appointment
today 15 minutes late and states that he has already used up all of the naproxen for the month in
25 days and would like to have his prescription filled early or get “something else that works
better.” He has tolerated naproxen well and has normal renal function. His height is 5’5” and he
weighs 201 lb. Three months ago he weighed 195 lb. His blood pressure today is 150/98, and 3
months ago it was 148/92. Mr A says that his back pain is “worse than ever” and that he is
having a great deal of trouble sleeping. He looks more disheveled than usual. Mr A grew up in a
mid-sized city in the northeast United States and completed high school there. He has no history
of substance abuse. He has worked in food services at the VA for 3 years and his job
performance has been above average. He is active in his community and engages in multiple
social activities. Occasionally he goes fishing with his brother.

Attribution_B Based on your impression of Mr. A, please select the number that you think best
describes Mr. A’s characteristics along the continuum. Your “best guess” is fine.
1
2
3
4
5
6
7
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1 (1)
Valuable ->
Dirty ->
Insincere ->
Safe ->
Warm - >
Wise ->
Strong ->
Unpredictable
->
Tense ->

2 (2)

o
o
o
o
o
o
o
o
o

o
o
o
o
o
o
o
o
o

3 (3)

o
o
o
o
o
o
o
o
o

4 (4)

o
o
o
o
o
o
o
o
o
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5 (5)

o
o
o
o
o
o
o
o
o

6 (6)

o
o
o
o
o
o
o
o
o

7 (7)

o
o
o
o
o
o
o
o
o

End of Block: Block B - OA
Start of Block: Block D - OA
Q318 DESCRIPTION OF MR. A Mr A is a 60-year-old male with hypertension, obesity, and
chronic low back pain. His X-ray shows evidence of arthritis. He has been coming to your clinic
for about 6 months, and this is his third visit. His current medications include lisinopril 40 mg
daily, naproxen 500 mg twice a day, fluoxetine 20 mg per day. He comes to his appointment
today 15 minutes late and states that he has already used up all of the naproxen for the month in
25 days and would like to have his prescription filled early or get “something else that works
better.” He has tolerated naproxen well and has normal renal function. His height is 5’5” and he
weighs 201 lb. Three months ago he weighed 195 lb. His blood pressure today is 150/98, and 3
months ago it was 148/92. Mr A says that his back pain is “worse than ever” and that he is
having a great deal of trouble sleeping. He looks more disheveled than usual. Mr A grew up in a
mid-sized city in the northeast United States and completed high school there. He has no history
of substance abuse. He has worked in food services at the VA for 3 years and his job
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performance has been above average. He is active in his community and engages in multiple
social activities. Occasionally he goes fishing with his brother.

Q319 For the following statements, assume that Mr. A is not your patient, but someone who has
lived in your neighborhood for the past two years. Please select the option that indicates your
response. Your “best guess" is fine.

Social_B Assuming Mr. A was not a patient of yours, how willing would you be to…
Definitely
Probably
Probably
Definitely
Willing (4)
Willing (3)
Unwilling (2)
Unwilling (1)
…move next
door to Mr. A?
(1)

o

o

o

o

…spend an
evening
socializing with
Mr. A? (2)

o

o

o

o

…make friends
with Mr. A? (3)

o

o

o

o

…have Mr. A
start working
closely with you
on a job? (4)

o

o

o

o

…have Mr. A
marry into your
family? (5)

o

o

o

o
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Violence_B In your opinion, how likely is it that...
Somewhat
Very Likely (1)
Likely (2)
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Somewhat
Unlikely (3)

Not Likely at
All (4)

…Mr. A would
do something
violent toward
other people? (1)

o

o

o

o

...Mr. A would
do something
violent toward
himself? (2)

o

o

o

o

End of Block: Block D - OA
Start of Block: SMI Older Adult Vignette Block
Q272 UNDERSTANDING DECISION-MAKING Instructions·
Please read the Description
of Mr. A. below.·
Once you have read the Description of Mr. A, assume all pertinent
information has been supplied that you need to answer the questions that follow.·
Assume you
have 30 minutes to see this patient.·
Assume all resources mentioned in the questions below
are available. DESCRIPTION OF MR. A Mr A is a 60-year-old male with schizophrenia,
hypertension, obesity, and chronic low back pain. His X-ray shows evidence of arthritis. He has
been coming to your clinic for about 6 months, and this is his third visit. His current medications
include lisinopril 40 mg daily, naproxen 500 mg twice a day, fluoxetine 20 mg per day and
risperidone 3 mg at bedtime. He comes to his appointment today 15 minutes late and states that
he has already used up all of the naproxen for the month in 25 days and would like to have his
prescription filled early or get “something else that works better.” He has tolerated naproxen well
and has normal renal function. His height is 5’5” and he weighs 201 lb. Three months ago he
weighed 195 lb. His blood pressure today is 150/98, and 3 months ago it was 148/92. Mr A says
that his back pain is “worse than ever” and that he is having a great deal of trouble sleeping. He
looks more disheveled than usual but reports no changes in his mental status. Mr A grew up in a
mid-sized city in the northeast United States and completed high school there. He has no history
of substance abuse. He has worked in food services at the VA for 3 years and his job
performance has been above average. He is active in his community and engages in multiple
social activities. Occasionally he goes fishing with his brother.
When answering the following questions, please assume that Mr. A is your patient. Select the
number that best indicates your response. Your “best guess” is fine. Please check “N/A” if a
question is not applicable to your role.
End of Block: SMI Older Adult Vignette Block
Start of Block: Block A - SMI OA
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Q322 DESCRIPTION OF MR. A Mr A is a 60-year-old male with schizophrenia, hypertension,
obesity, and chronic low back pain. His X-ray shows evidence of arthritis. He has been coming
to your clinic for about 6 months, and this is his third visit. His current medications include
lisinopril 40 mg daily, naproxen 500 mg twice a day, fluoxetine 20 mg per day and risperidone 3
mg at bedtime. He comes to his appointment today 15 minutes late and states that he has already
used up all of the naproxen for the month in 25 days and would like to have his prescription
filled early or get “something else that works better.” He has tolerated naproxen well and has
normal renal function. His height is 5’5” and he weighs 201 lb. Three months ago he weighed
195 lb. His blood pressure today is 150/98, and 3 months ago it was 148/92. Mr A says that his
back pain is “worse than ever” and that he is having a great deal of trouble sleeping. He looks
more disheveled than usual but reports no changes in his mental status. Mr A grew up in a midsized city in the northeast United States and completed high school there. He has no history of
substance abuse. He has worked in food services at the VA for 3 years and his job performance
has been above average. He is active in his community and engages in multiple social activities.
Occasionally he goes fishing with his brother.
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Referral_C How likely, if at all...
Not at
All
Likely
- 1 (1)

2
(2)

3
(3)

4
(4)

5
(5)

6
(6)

7
(7)

8
(8)

9
(9)

Extremely
Likely 10 (10)

N/A
for
my
role
(11)

… would
you be to
recommend
that this
patient be
referred to a
local weight
reduction
program at
this time?
(1)

o

o o o o o o o o o

o

…would
you be to
recommend
that this
patient be
referred to a
local pain
management
program at
this time?
(2)

o

o o o o o o o o o

o

…would
you be to
recommend
that this
patient be
referred to a
sleep study
at this time?
(3)

o

o o o o o o o o o

o
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Adherence_C How likely, if at all...
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Not at
All
Likely
- 1 (1)

2 (2)

3 (3)

4 (4)

5 (5)

6 (6)

82

7 (7)

8 (8)

9 (9)

Extremely
Likely 10 (10)

…do you
think it is that
this patient
will adhere to
his
medications?
(1)

o

o o o o o o o o

o

…do you
think it is that
this patient
will keep his
regular
appointments?
(2)

o

o o o o o o o o

o

…do you
think Mr. A
will refill his
medications
on time? (3)

o

o o o o o o o o

o

...do you think
Mr. A would
be to read
educational
material you
provide about
hypertension
(written at a
6th grade
level)? (4)

o

o o o o o o o o

o

…do you
think it is that
this patient
would
understand
the written
material about
hypertension?
(5)

o

o o o o o o o o

o
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…do you
think Mr. A
would be to
read
educational
material you
provide about
nutrition and
diet (written
at a 6th grade
level)? (6)

o

o o o o o o o o

o

…do you
think it is that
this patient
would
understand
the written
material about
nutrition and
diet? (7)

o

o o o o o o o o

o
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Prognosis_C How likely, if at all...
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Not at
All
Likely
- 1 (1)

2 (2)

3 (3)

4 (4)

5 (5)

6 (6)

85

7 (7)

8 (8)

9 (9)

Extremely
Likely 10 (10)

…would
you be to
involve this
patient’s
family in his
care or his
treatment
plan? (1)

o

o o o o o o o o

o

…would
you be to
discuss your
concerns
about this
patient with
his brother?
(2)

o

o o o o o o o o

o

...would you
be to ask
Mr. A to
bring his
brother to an
appointment
with you?
(3)

o

o o o o o o o o

o

… do you
think it is
that this
patient’s
hypertension
can be better
controlled
with diet
and
medication?
(4)

o

o o o o o o o o

o
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... do you
think that
Mr. A’s pain
can be
reduced? (5)

o

o o o o o o o o

o

…do you
think this
patient’s
general
health status
will worsen
in the
coming
year? (6)

o

o o o o o o o o

o

…do you
think this
patient is to
advance in
his job? (7)

o

o o o o o o o o

o

…do you
think this
patient
would get
together
socially with
friends or
neighbors
on a regular
basis? (8)

o

o o o o o o o o

o

…do you
think this
patient
would be
able to live
on his own?
(9)

o

o o o o o o o o

o
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VisitTime_C In a 30 minute visit, about how much time would you spend discussing
treatment options with this patient?
________________________________________________________________
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Competence_C In your opinion, how able is...
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Very Able (4)

Somewhat Able
(3)

89

Somewhat
Unable (2)

Not Able at All
(1)

…Mr. A to make
his own
decisions about
the treatment he
should receive?
(1)

o

o

o

o

…Mr. A to make
his own
decisions about
managing his
own money? (2)

o

o

o

o

...Mr. A to
discuss the
content of items
discussed with
you and to offer
a fairly clear
version of it. (5)

o

o

o

o

...Mr. A to
mention specific
consequences
related to his
treatment
options (6)

o

o

o

o

...Mr. A to state
a treatment
choice, or to
indicate desire
for a
professional or
other responsible
person to make a
treatment choice
for him. (7)

o

o

o

o

…that Mr. A’s
situation will
improve on its
own? (3)

o

o

o

o
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…that Mr. A’s
situation will
improve with
treatment? (4)

o

o

90

o

o

End of Block: Block A - SMI OA
Start of Block: Block C - SMI OA
Q328 DESCRIPTION OF MR. A Mr A is a 60-year-old male with schizophrenia, hypertension,
obesity, and chronic low back pain. His X-ray shows evidence of arthritis. He has been coming
to your clinic for about 6 months, and this is his third visit. His current medications include
lisinopril 40 mg daily, naproxen 500 mg twice a day, fluoxetine 20 mg per day and risperidone 3
mg at bedtime. He comes to his appointment today 15 minutes late and states that he has already
used up all of the naproxen for the month in 25 days and would like to have his prescription
filled early or get “something else that works better.” He has tolerated naproxen well and has
normal renal function. His height is 5’5” and he weighs 201 lb. Three months ago he weighed
195 lb. His blood pressure today is 150/98, and 3 months ago it was 148/92. Mr A says that his
back pain is “worse than ever” and that he is having a great deal of trouble sleeping. He looks
more disheveled than usual but reports no changes in his mental status. Mr A grew up in a midsized city in the northeast United States and completed high school there. He has no history of
substance abuse. He has worked in food services at the VA for 3 years and his job performance
has been above average. He is active in his community and engages in multiple social activities.
Occasionally he goes fishing with his brother.

Q329 When answering the following questions, assume that Mr. A is your patient. Please select
the number that indicates how much you agree or disagree with the following statements. Your
“best guess” is fine.
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Attitude_C Assuming Mr. A were your patient, how much, if at all, do you agree with the
following statements?
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Not
at All
-1
(1)

2 (2)

3 (3)

4 (4)

5 (5)

6 (6)
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7 (7)

8 (8)

9 (9)

Extremely
Likely 10 (10)

I would
feel pity
for Mr. A.
(1)

o o o o o o o o o

o

I would
think that
it was Mr.
A’s own
fault that
he is in the
present
condition.
(2)

o o o o o o o o o

o

I would
think that
Mr. A is
dangerous.
(3)

o o o o o o o o o

o

I would
think that
Mr. A
should be
forced into
treatment
with his
doctor
even if he
does not
want
treatment.
(4)

o o o o o o o o o

o

I would be
angry with
Mr. A. (5)

o o o o o o o o o

o

I would be
scared of
Mr. A. (6)

o o o o o o o o o

o
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I would
think I can
help Mr.
A. (7)

o o o o o o o o o

o

I would
try to stay
away from
Mr. A. (8)

o o o o o o o o o

o

End of Block: Block C - SMI OA
Start of Block: Block B - SMI OA
Q331 DESCRIPTION OF MR. A Mr A is a 60-year-old male with schizophrenia, hypertension,
obesity, and chronic low back pain. His X-ray shows evidence of arthritis. He has been coming
to your clinic for about 6 months, and this is his third visit. His current medications include
lisinopril 40 mg daily, naproxen 500 mg twice a day, fluoxetine 20 mg per day and risperidone 3
mg at bedtime. He comes to his appointment today 15 minutes late and states that he has already
used up all of the naproxen for the month in 25 days and would like to have his prescription
filled early or get “something else that works better.” He has tolerated naproxen well and has
normal renal function. His height is 5’5” and he weighs 201 lb. Three months ago he weighed
195 lb. His blood pressure today is 150/98, and 3 months ago it was 148/92. Mr A says that his
back pain is “worse than ever” and that he is having a great deal of trouble sleeping. He looks
more disheveled than usual but reports no changes in his mental status. Mr A grew up in a midsized city in the northeast United States and completed high school there. He has no history of
substance abuse. He has worked in food services at the VA for 3 years and his job performance
has been above average. He is active in his community and engages in multiple social activities.
Occasionally he goes fishing with his brother.

Attribution_C Based on your impression of Mr. A, please select the number that you think best
describes Mr. A’s characteristics along the continuum. Your “best guess” is fine.
1
2
3
4
5
6
7
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1 (1)
Valuable ->
Dirty ->
Insincere ->
Safe ->
Warm - >
Wise ->
Strong ->
Unpredictable
->
Tense ->

o
o
o
o
o
o
o
o
o

2 (2)

o
o
o
o
o
o
o
o
o

3 (3)

o
o
o
o
o
o
o
o
o

4 (4)

o
o
o
o
o
o
o
o
o
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5 (5)

o
o
o
o
o
o
o
o
o

6 (6)

o
o
o
o
o
o
o
o
o

7 (7)

o
o
o
o
o
o
o
o
o

End of Block: Block B - SMI OA
Start of Block: Block D - SMI OA
Q333 DESCRIPTION OF MR. A Mr A is a 60-year-old male with schizophrenia, hypertension,
obesity, and chronic low back pain. His X-ray shows evidence of arthritis. He has been coming
to your clinic for about 6 months, and this is his third visit. His current medications include
lisinopril 40 mg daily, naproxen 500 mg twice a day, fluoxetine 20 mg per day and risperidone 3
mg at bedtime. He comes to his appointment today 15 minutes late and states that he has already
used up all of the naproxen for the month in 25 days and would like to have his prescription
filled early or get “something else that works better.” He has tolerated naproxen well and has
normal renal function. His height is 5’5” and he weighs 201 lb. Three months ago he weighed
195 lb. His blood pressure today is 150/98, and 3 months ago it was 148/92. Mr A says that his
back pain is “worse than ever” and that he is having a great deal of trouble sleeping. He looks
more disheveled than usual but reports no changes in his mental status. Mr A grew up in a midsized city in the northeast United States and completed high school there. He has no history of
substance abuse. He has worked in food services at the VA for 3 years and his job performance
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has been above average. He is active in his community and engages in multiple social activities.
Occasionally he goes fishing with his brother.

Q334 For the following statements, assume that Mr. A is not your patient, but someone who has
lived in your neighborhood for the past two years. Please select the option that indicates your
response. Your “best guess" is fine.

Social_C Assuming Mr. A was not a patient of yours, how willing would you be to…
Definitely
Probably
Probably
Definitely
Willing (4)
Willing (3)
Unwilling (2)
Unwilling (1)
…move next
door to Mr. A?
(1)

o

o

o

o

…spend an
evening
socializing with
Mr. A? (2)

o

o

o

o

…make friends
with Mr. A? (3)

o

o

o

o

…have Mr. A
start working
closely with you
on a job? (4)

o

o

o

o

…have Mr. A
marry into your
family? (5)

o

o

o

o
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Violence_C In your opinion, how likely is it that...
Somewhat
Very Likely (1)
Likely (2)
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Somewhat
Unlikely (3)

Not Likely at
All (4)

…Mr. A would
do something
violent toward
other people? (1)

o

o

o

o

...Mr. A would
do something
violent toward
himself? (2)

o

o

o

o

End of Block: Block D - SMI OA
Start of Block: SMI Vignette Block
Q274 UNDERSTANDING DECISION-MAKING Instructions·
Please read the Description
of Mr. A. below.·
Once you have read the Description of Mr. A, assume all pertinent
information has been supplied that you need to answer the questions that follow.·
Assume you
have 30 minutes to see this patient.·
Assume all resources mentioned in the questions below
are available. DESCRIPTION OF MR. A Mr A is a 34-year-old male with schizophrenia,
hypertension, obesity, and chronic low back pain. His X-ray shows evidence of arthritis. He has
been coming to your clinic for about 6 months, and this is his third visit. His current medications
include lisinopril 40 mg daily, naproxen 500 mg twice a day, fluoxetine 20 mg per day and
risperidone 3 mg at bedtime. He comes to his appointment today 15 minutes late and states that
he has already used up all of the naproxen for the month in 25 days and would like to have his
prescription filled early or get “something else that works better.” He has tolerated naproxen
well. His height is 5’5” and he weighs 201 lb. Three months ago he weighed 195 lb. His blood
pressure today is 150/98, and 3 months ago it was 148/92. Mr A says that his back pain is “worse
than ever” and that he is having a great deal of trouble sleeping. He looks more disheveled than
usual but reports no changes in his mental status. Mr A grew up in a mid-sized city in the
northeast United States and completed high school there. He has no history of substance abuse.
He has worked in food services at the VA for 3 years and his job performance has been above
average. He is active in his community and engages in multiple social activities. Occasionally he
goes fishing with his brother.
When answering the following questions, please assume that Mr. A is your patient. Select the
number that best indicates your response. Your “best guess” is fine. Please check “N/A” if a
question is not applicable to your role.
End of Block: SMI Vignette Block
Start of Block: Block A - SMI
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Q302 DESCRIPTION OF MR. A Mr A is a 34-year-old male with schizophrenia, hypertension,
obesity, and chronic low back pain. His X-ray shows evidence of arthritis. He has been coming
to your clinic for about 6 months, and this is his third visit. His current medications include
lisinopril 40 mg daily, naproxen 500 mg twice a day, fluoxetine 20 mg per day and risperidone 3
mg at bedtime. He comes to his appointment today 15 minutes late and states that he has already
used up all of the naproxen for the month in 25 days and would like to have his prescription
filled early or get “something else that works better.” He has tolerated naproxen well. His height
is 5’5” and he weighs 201 lb. Three months ago he weighed 195 lb. His blood pressure today is
150/98, and 3 months ago it was 148/92. Mr A says that his back pain is “worse than ever” and
that he is having a great deal of trouble sleeping. He looks more disheveled than usual but reports
no changes in his mental status. Mr A grew up in a mid-sized city in the northeast United States
and completed high school there. He has no history of substance abuse. He has worked in food
services at the VA for 3 years and his job performance has been above average. He is active in
his community and engages in multiple social activities. Occasionally he goes fishing with his
brother.
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Referral_D How likely, if at all...
Not at
All
Likely
- 1 (1)

2
(2)

3
(3)

4
(4)

5
(5)

6
(6)

7
(7)

8
(8)

9
(9)

Extremely
Likely 10 (10)

N/A
for
my
role
(11)

… would
you be to
recommend
that this
patient be
referred to a
local weight
reduction
program at
this time?
(1)

o

o o o o o o o o o

o

…would
you be to
recommend
that this
patient be
referred to a
local pain
management
program at
this time?
(2)

o

o o o o o o o o o

o

…would
you be to
recommend
that this
patient be
referred to a
sleep study
at this time?
(3)

o

o o o o o o o o o

o
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Adherence_D How likely, if at all...
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Not at
All
Likely
- 1 (1)

2 (2)

3 (3)

4 (4)

5 (5)

6 (6)

100

7 (7)

8 (8)

9 (9)

Extremely
Likely 10 (10)

…do you
think it is that
this patient
will adhere to
his
medications?
(1)

o

o o o o o o o o

o

…do you
think it is that
this patient
will keep his
regular
appointments?
(2)

o

o o o o o o o o

o

…do you
think Mr. A
will refill his
medications
on time? (3)

o

o o o o o o o o

o

...do you think
Mr. A would
be to read
educational
material you
provide about
hypertension
(written at a
6th grade
level)? (4)

o

o o o o o o o o

o

…do you
think it is that
this patient
would
understand
the written
material about
hypertension?
(5)

o

o o o o o o o o

o
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…do you
think Mr. A
would be to
read
educational
material you
provide about
nutrition and
diet (written
at a 6th grade
level)? (6)

o

o o o o o o o o

o

…do you
think it is that
this patient
would
understand
the written
material about
nutrition and
diet? (7)

o

o o o o o o o o

o
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Prognosis_D How likely, if at all...
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Not at
All
Likely
- 1 (1)

2 (2)

3 (3)

4 (4)

5 (5)

6 (6)
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7 (7)

8 (8)

9 (9)

Extremely
Likely 10 (10)

…would
you be to
involve this
patient’s
family in his
care or his
treatment
plan? (1)

o

o o o o o o o o

o

…would
you be to
discuss your
concerns
about this
patient with
his brother?
(2)

o

o o o o o o o o

o

...would you
be to ask
Mr. A to
bring his
brother to an
appointment
with you?
(3)

o

o o o o o o o o

o

… do you
think it is
that this
patient’s
hypertension
can be better
controlled
with diet
and
medication?
(4)

o

o o o o o o o o

o
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... do you
think that
Mr. A’s pain
can be
reduced? (5)

o

o o o o o o o o

o

…do you
think this
patient’s
general
health status
will worsen
in the
coming
year? (6)

o

o o o o o o o o

o

…do you
think this
patient is to
advance in
his job? (7)

o

o o o o o o o o

o

…do you
think this
patient
would get
together
socially with
friends or
neighbors
on a regular
basis? (8)

o

o o o o o o o o

o

…do you
think this
patient
would be
able to live
on his own?
(9)

o

o o o o o o o o

o
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VisitTime_D In a 30 minute visit, about how much time would you spend discussing
treatment options with this patient?
________________________________________________________________
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Competence_D In your opinion, how able is...
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Very Able (4)

Somewhat Able
(3)

107

Somewhat
Unable (2)

Not Able at All
(1)

…Mr. A to make
his own
decisions about
the treatment he
should receive?
(1)

o

o

o

o

…Mr. A to make
his own
decisions about
managing his
own money? (2)

o

o

o

o

...Mr. A to
discuss the
content of items
discussed with
you and to offer
a fairly clear
version of it. (5)

o

o

o

o

...Mr. A to
mention specific
consequences
related to his
treatment
options (6)

o

o

o

o

...Mr. A to state
a treatment
choice, or to
indicate desire
for a
professional or
other responsible
person to make a
treatment choice
for him. (7)

o

o

o

o

…that Mr. A’s
situation will
improve on its
own? (3)

o

o

o

o
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…that Mr. A’s
situation will
improve with
treatment? (4)

o

o
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o

o

End of Block: Block A - SMI
Start of Block: Block C - SMI
Q303 DESCRIPTION OF MR. A Mr A is a 34-year-old male with schizophrenia, hypertension,
obesity, and chronic low back pain. His X-ray shows evidence of arthritis. He has been coming
to your clinic for about 6 months, and this is his third visit. His current medications include
lisinopril 40 mg daily, naproxen 500 mg twice a day, fluoxetine 20 mg per day and risperidone 3
mg at bedtime. He comes to his appointment today 15 minutes late and states that he has already
used up all of the naproxen for the month in 25 days and would like to have his prescription
filled early or get “something else that works better.” He has tolerated naproxen well. His height
is 5’5” and he weighs 201 lb. Three months ago he weighed 195 lb. His blood pressure today is
150/98, and 3 months ago it was 148/92. Mr A says that his back pain is “worse than ever” and
that he is having a great deal of trouble sleeping. He looks more disheveled than usual but reports
no changes in his mental status. Mr A grew up in a mid-sized city in the northeast United States
and completed high school there. He has no history of substance abuse. He has worked in food
services at the VA for 3 years and his job performance has been above average. He is active in
his community and engages in multiple social activities. Occasionally he goes fishing with his
brother.

Q297 When answering the following questions, assume that Mr. A is your patient. Please select
the number that indicates how much you agree or disagree with the following statements. Your
“best guess” is fine.

INFLUENCE ON PROVIDERS’ DECISION MAKING

Attitude_D Assuming Mr. A were your patient, how much, if at all, do you agree with the
following statements?
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Not
at All
-1
(1)

2 (2)

3 (3)

4 (4)

5 (5)

6 (6)

110

7 (7)

8 (8)

9 (9)

Extremely
Likely 10 (10)

I would
feel pity
for Mr. A.
(1)

o o o o o o o o o

o

I would
think that
it was Mr.
A’s own
fault that
he is in the
present
condition.
(2)

o o o o o o o o o

o

I would
think that
Mr. A is
dangerous.
(3)

o o o o o o o o o

o

I would
think that
Mr. A
should be
forced into
treatment
with his
doctor
even if he
does not
want
treatment.
(4)

o o o o o o o o o

o

I would be
angry with
Mr. A. (5)

o o o o o o o o o

o

I would be
scared of
Mr. A. (6)

o o o o o o o o o

o
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I would
think I can
help Mr.
A. (7)

o o o o o o o o o

o

I would
try to stay
away from
Mr. A. (8)

o o o o o o o o o

o

End of Block: Block C - SMI
Start of Block: Block B - SMI
Q304 DESCRIPTION OF MR. A Mr A is a 34-year-old male with schizophrenia, hypertension,
obesity, and chronic low back pain. His X-ray shows evidence of arthritis. He has been coming
to your clinic for about 6 months, and this is his third visit. His current medications include
lisinopril 40 mg daily, naproxen 500 mg twice a day, fluoxetine 20 mg per day and risperidone 3
mg at bedtime. He comes to his appointment today 15 minutes late and states that he has already
used up all of the naproxen for the month in 25 days and would like to have his prescription
filled early or get “something else that works better.” He has tolerated naproxen well. His height
is 5’5” and he weighs 201 lb. Three months ago he weighed 195 lb. His blood pressure today is
150/98, and 3 months ago it was 148/92. Mr A says that his back pain is “worse than ever” and
that he is having a great deal of trouble sleeping. He looks more disheveled than usual but reports
no changes in his mental status. Mr A grew up in a mid-sized city in the northeast United States
and completed high school there. He has no history of substance abuse. He has worked in food
services at the VA for 3 years and his job performance has been above average. He is active in
his community and engages in multiple social activities. Occasionally he goes fishing with his
brother.

Attribution_D Based on your impression of Mr. A, please select the number that you think best
describes Mr. A’s characteristics along the continuum. Your “best guess” is fine.
1
2
3
4
5
6
7
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1 (1)
Valuable ->
Dirty ->
Insincere ->
Safe ->
Warm - >
Wise ->
Strong ->
Unpredictable
->
Tense ->

2 (2)

o
o
o
o
o
o
o
o
o

o
o
o
o
o
o
o
o
o

3 (3)

o
o
o
o
o
o
o
o
o

4 (4)

o
o
o
o
o
o
o
o
o
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5 (5)

o
o
o
o
o
o
o
o
o

6 (6)

o
o
o
o
o
o
o
o
o

7 (7)

o
o
o
o
o
o
o
o
o

End of Block: Block B - SMI
Start of Block: Block D - SMI
Q305 DESCRIPTION OF MR. A Mr A is a 34-year-old male with schizophrenia, hypertension,
obesity, and chronic low back pain. His X-ray shows evidence of arthritis. He has been coming
to your clinic for about 6 months, and this is his third visit. His current medications include
lisinopril 40 mg daily, naproxen 500 mg twice a day, fluoxetine 20 mg per day and risperidone 3
mg at bedtime. He comes to his appointment today 15 minutes late and states that he has already
used up all of the naproxen for the month in 25 days and would like to have his prescription
filled early or get “something else that works better.” He has tolerated naproxen well. His height
is 5’5” and he weighs 201 lb. Three months ago he weighed 195 lb. His blood pressure today is
150/98, and 3 months ago it was 148/92. Mr A says that his back pain is “worse than ever” and
that he is having a great deal of trouble sleeping. He looks more disheveled than usual but reports
no changes in his mental status. Mr A grew up in a mid-sized city in the northeast United States
and completed high school there. He has no history of substance abuse. He has worked in food
services at the VA for 3 years and his job performance has been above average. He is active in
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his community and engages in multiple social activities. Occasionally he goes fishing with his
brother.

Q300 For the following statements, assume that Mr. A is not your patient, but someone who has
lived in your neighborhood for the past two years. Please select the option that indicates your
response. Your “best guess" is fine.

Social_D Assuming Mr. A was not a patient of yours, how willing would you be to…
Definitely
Probably
Probably
Definitely
Willing (4)
Willing (3)
Unwilling (2)
Unwilling (1)
…move next
door to Mr. A?
(1)

o

o

o

o

…spend an
evening
socializing with
Mr. A? (2)

o

o

o

o

…make friends
with Mr. A? (3)

o

o

o

o

…have Mr. A
start working
closely with you
on a job? (4)

o

o

o

o

…have Mr. A
marry into your
family? (5)

o

o

o

o
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Violence_D In your opinion, how likely is it that...
Somewhat
Very Likely (1)
Likely (2)
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Somewhat
Unlikely (3)

Not Likely at
All (4)

…Mr. A would
do something
violent toward
other people? (1)

o

o

o

o

...Mr. A would
do something
violent toward
himself? (2)

o

o

o

o

End of Block: Block D - SMI
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Appendix B: Institutional Review Board Approval
Aug 13, 2018 11:21 AM EDT
Michael Vriesman
Psychology, Users loaded with unmatched Organization affiliation.
Re: Exempt - Initial - UHSRC-FY17-18-245 The Influence of Patient Age and Schizophrenia
Diagnosis on Providers’ Decision Making
Dear Dr. Michael Vriesman:
The Eastern Michigan University Human Subjects Review Committee has rendered the decision
below for The Influence of Patient Age and Schizophrenia Diagnosis on Providers’ Decision
Making. You may begin your research.
Decision: Exempt
Selected Category: Category 2. Research involving the use of educational tests (cognitive,
diagnostic, aptitude, achievement), survey procedures, interview procedures or observation of
public behavior, unless: (i) information obtained is recorded in such a manner that human
subjects can be identified, directly or through identifiers linked to the subjects; and (ii) any
disclosure of the human subjects' responses outside the research could reasonably place the
subjects at risk of criminal or civil liability or be damaging to the subjects' financial standing,
employability, or reputation.
Renewals: Exempt studies do not need to be renewed. When the project is completed, please
contact human.subjects@emich.edu.
Modifications: Any plan to alter the study design or any study documents must be reviewed to
determine if the Exempt decision changes. You must submit a modification request application
in Cayuse IRB and await a decision prior to implementation.
Problems: Any deviations from the study protocol, unanticipated problems, adverse events,
subject complaints, or other problems that may affect the risk to human subjects must be reported
to the UHSRC. Complete an incident report in Cayuse IRB.
Follow-up: Please contact the UHSRC when your project is complete. Please contact
human.subjects@emich.edu with any questions or concerns.
Sincerely,
Eastern Michigan University Human Subjects Review Committee
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Appendix C: Vignette
Original vignette
Mr A is a 34-year-old male with [schizophrenia], hypertension, obesity, and chronic low back
pain. His X-ray shows evidence of arthritis. He has been coming to your clinic for about 6
months, and this is his third visit. His current medications include lisinopril 40 mg daily,
naproxen 500 mg twice a day, fluoxetine 20 mg per day [and risperidone 3 mg at bedtime]. He
comes to his appointment today 15 minutes late and states that he has already used up all of the
naproxen for the month in 25 days and would like to have his prescription filled early or get
“something else that works better.” He has tolerated naproxen well. His height is 5’5” and he
weighs 201 lb. Three months ago he weighed 195 lb. His blood pressure today is 150/98, and 3
months ago it was 148/92. Mr A says that his back pain is “worse than ever” and that he is
having a great deal of trouble sleeping. He looks more disheveled than usual [but reports no
changes in his mental status]. Mr A grew up in Manchester, New Hampshire, and completed
high school there. He has no history of substance abuse. He lives with his brother and has
worked in food services at the VA for 3 years. His job performance has been above average. He
attends church and church functions frequently and enjoys reading magazines. Occasionally he
goes fishing with his brother.
Comparison vignette
Mr A is a 34-year-old male with, hypertension, obesity, and chronic low back pain. His X-ray
shows evidence of arthritis. He has been coming to your clinic for about 6 months, and this is his
third visit. His current medications include lisinopril 40 mg daily, naproxen 500 mg twice a day,
fluoxetine 20 mg per day. He comes to his appointment today 15 minutes late and states that he
has already used up all of the naproxen for the month in 25 days and would like to have his
prescription filled early or get “something else that works better.” He has tolerated naproxen
well. His height is 5’5” and he weighs 201 lb. Three months ago he weighed 195 lb. His blood
pressure today is 150/98, and 3 months ago it was 148/92. Mr A says that his back pain is “worse
than ever” and that he is having a great deal of trouble sleeping. He looks more disheveled than
usual. Mr A grew up in Manchester, New Hampshire, and completed high school there. He has
no history of substance abuse. He lives with his brother and has worked in food services at the
VA for 3 years. His job performance has been above average. He attends church and church
functions frequently and enjoys reading magazines. Occasionally he goes fishing with his
brother.
SMI Vignette
Mr A is a 34-year-old male with schizophrenia, hypertension, obesity, and chronic low back
pain. His X-ray shows evidence of arthritis. He has been coming to your clinic for about 6
months, and this is his third visit. His current medications include lisinopril 40 mg daily,
naproxen 500 mg twice a day, fluoxetine 20 mg per day and risperidone 3 mg at bedtime. He
comes to his appointment today 15 minutes late and states that he has already used up all of the
naproxen for the month in 25 days and would like to have his prescription filled early or get
“something else that works better.” He has tolerated naproxen well. His height is 5’5” and he
weighs 201 lb. Three months ago he weighed 195 lb. His blood pressure today is 150/98, and 3
months ago it was 148/92. Mr A says that his back pain is “worse than ever” and that he is
having a great deal of trouble sleeping. He looks more disheveled than usual but reports no
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changes in his mental status. Mr A grew up in Manchester, New Hampshire, and completed high
school there. He has no history of substance abuse. He lives with his brother and has worked in
food services at the VA for 3 years. His job performance has been above average. He attends
church and church functions frequently and enjoys reading magazines. Occasionally he goes
fishing with his brother.
Older adult vignette
Mr A is a 75-year-old male with hypertension, obesity, and chronic low back pain. His X-ray
shows evidence of arthritis. He has been coming to your clinic for about 6 months, and this is his
third visit. His current medications include lisinopril 40 mg daily, naproxen 500 mg twice a day,
fluoxetine 20 mg per day. He comes to his appointment today 15 minutes late and states that he
has already used up all of the naproxen for the month in 25 days and would like to have his
prescription filled early or get “something else that works better.” He has tolerated naproxen well
and has normal renal function. His height is 5’5” and he weighs 201 lb. Three months ago he
weighed 195 lb. His blood pressure today is 150/98, and 3 months ago it was 148/92. Mr A says
that his back pain is “worse than ever” and that he is having a great deal of trouble sleeping. He
looks more disheveled than usual. Mr A grew up in Manchester, New Hampshire, and completed
high school there. He has no history of substance abuse. He lives with his brother and has
worked in food services at the VA for 3 years. His job performance has been above average. He
attends church and church functions frequently and enjoys reading magazines. Occasionally he
goes fishing with his brother.
SMI and older adult vignette
Mr A is a 75-year-old male with schizophrenia, hypertension, obesity, and chronic low back
pain. His X-ray shows evidence of arthritis. He has been coming to your clinic for about 6
months, and this is his third visit. His current medications include lisinopril 40 mg daily,
naproxen 500 mg twice a day, fluoxetine 20 mg per day and risperidone 3 mg at bedtime. He
comes to his appointment today 15 minutes late and states that he has already used up all of the
naproxen for the month in 25 days and would like to have his prescription filled early or get
“something else that works better.” He has tolerated naproxen well and has normal renal
function. His height is 5’5” and he weighs 201 lb. Three months ago he weighed 195 lb. His
blood pressure today is 150/98, and 3 months ago it was 148/92. Mr A says that his back pain is
“worse than ever” and that he is having a great deal of trouble sleeping. He looks more
disheveled than usual but reports no changes in his mental status. Mr A grew up in Manchester,
New Hampshire, and completed high school there. He has no history of substance abuse. He
lives with his brother and has worked in food services at the VA for 3 years. His job performance
has been above average. He attends church and church functions frequently and enjoys reading
magazines. Occasionally he goes fishing with his brother.
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Appendix D: Email to Potential Participants
(Subject) Graduate research on healthcare providers’ decision making
Hello,
My name is Michael Vriesman and I am a PhD student in Clinical Psychology at Eastern
Michigan University under the mentorship of Dr. Alexandros Maragakis. We are conducting an
online survey of how healthcare providers make decisions on their patient’s care. This survey
should take approximately 15-20 minutes to complete. Participants have a chance to win one of
four $50 gift cards, if they include their email at the end of the survey. It would greatly assist my
research if you would complete and/or forward this survey to other healthcare providers you
know or work with.
Thank you for your time,
Michael Vriesman
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Appendix E: R Code
# Michael's thesis data
# Variables ---# (DV)Comp: 1-4 scale
# (DV)Adhere: 1-10 scale
# (DV)Educ: 1-10 scale
# (DV)Weightref: 1-10 scale
# (DV)Painref: 1-10 scale
# (DV)Sleepref: 1-10 scale
# (IV)Vignette: 1-4 categories 1)comparison, 2)w/ schizophrenia, 3)older adult, 4)older adult w/
schizophrenia
# (CV)Yearprac: 1- 50 yrs
# (CV)ProvtypeGrp: 1-2 categories: 1) Behavioral Health Training; 2) Medical Training
# (CV)Age: 1-5 categories: 1) Less than 30 2) 31-40 3) 41-50 4) 51-60 5)Over 61
# (CV)Area: 0-1 categories: 0) Mental Health 1) Primary Care
# Load packages ---library(multcomp)
library(apaTables)
library(pastecs)
library(car)
library(boot)
# Read and restructure data ---# Read in data [Note: after Qualtrics export (as numeric), rows 2 & 3 were deleted]
tRaw <- read.csv(file='ThesisdataF.csv', header = TRUE)
# omit cases that did not answer the majority of items
tRaw <- tRaw[tRaw$Progress > 80,]
# add a subID so each respondent is labeled with a unique ID
tRaw$subID <- 1:nrow(tRaw)
# specify demograph columns, allows easy access to all demographic variables
demoCols <- names(tRaw)[c(60,62:64,66,68,70:72)]
# create separate data frames for each vignette
tCompRaw <- tRaw[,c("subID",names(tRaw)[grep("_A",names(tRaw))])]
tOARaw <- tRaw[,c("subID",names(tRaw)[grep("_B",names(tRaw))])]
tSMIoaRaw <- tRaw[,c("subID",names(tRaw)[grep("_C",names(tRaw))])]
tSMIRaw <- tRaw[,c("subID",names(tRaw)[grep("_D",names(tRaw))])]
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# keep only valid cases per vignette data frame
tComp <- tCompRaw[rowSums(is.na(tCompRaw[,-1])) < 48, ]
tOA <- tOARaw[rowSums(is.na(tOARaw[,-1])) < 48, ]
tSMIoa <- tSMIoaRaw[rowSums(is.na(tSMIoaRaw[,-1])) < 48, ]
tSMI <- tSMIRaw[rowSums(is.na(tSMIRaw[,-1])) < 48, ]
# add in missing columns (Qualtrics error) to comparison group
tComp$Adherence_6 <- NA
tComp$Adherence_7 <- NA
tComp$Competence_7 <- NA
# rename columns to get rid of _X_ where X is A, B, C, or D, to allow for combination of all
vignettes responses into one row
colnames(tComp) <c("subID",paste0("Referral_",1:3),paste0("Adherence_",1:5),paste0("Prognosis_",1:9),
"visitTime",paste0("Competence_",1:6),paste0("Attitude_",1:8),
paste0("Attribution_",1:9),paste0("Social_",1:5),paste0("Violence_",1:2),
"Adherence_6","Adherence_7","Competence_7")
colnames(tOA) <c("subID",paste0("Referral_",1:3),paste0("Adherence_",1:7),paste0("Prognosis_",1:9),
"visitTime",paste0("Competence_",1:7),paste0("Attitude_",1:8),
paste0("Attribution_",1:9),paste0("Social_",1:5),paste0("Violence_",1:2))
colnames(tSMIoa) <c("subID",paste0("Referral_",1:3),paste0("Adherence_",1:7),paste0("Prognosis_",1:9),
"visitTime",paste0("Competence_",1:7),paste0("Attitude_",1:8),
paste0("Attribution_",1:9),paste0("Social_",1:5),paste0("Violence_",1:2))
colnames(tSMI) <c("subID",paste0("Referral_",1:3),paste0("Adherence_",1:7),paste0("Prognosis_",1:9),
"visitTime",paste0("Competence_",1:7),paste0("Attitude_",1:8),
paste0("Attribution_",1:9),paste0("Social_",1:5),paste0("Violence_",1:2))
# add column for vignette
tComp$Vignette <- "acomparison"
tOA$Vignette <- "older adult"
tSMIoa$Vignette <- "combined"
tSMI$Vignette <- "SMI"
# stack data frames, creating one column for vignette
tQuest <- rbind(tComp,tOA,tSMIoa,tSMI)
# merge with demographic, so that all demographic information matches with responses
Thesisdata <- merge(tRaw[,c("subID",demoCols)],tQuest, by = "subID")
# rename some columns
colnames(Thesisdata)[colnames(Thesisdata)=="specialty"] <- "Area"
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colnames(Thesisdata)[colnames(Thesisdata)=="profess"] <- "Provtype"
colnames(Thesisdata)[colnames(Thesisdata)=="pracYear"] <- "Yearprac"
colnames(Thesisdata)[colnames(Thesisdata)=="age"] <- "Age"
# recode attribution items, for items that needed to be reverse coded
attRev <- paste0("Attribution_",c(1,4,5,6,7))
tAttrFrame <- 8 - Thesisdata[,attRev]
colnames(tAttrFrame) <- paste0("Attribution_",c(1,4,5,6,7),"_R")
# add reverse code to larger data frame
Thesisdata <- cbind(Thesisdata,tAttrFrame)
#Make Area of Practice a categorical variable
Thesisdata$Area <- factor(Thesisdata$Area, levels = c(1,0), labels = c("Mental Health","Primary
Care"))
#Make Provider type a categorical variable
Thesisdata$Provtype <- factor(Thesisdata$Provtype, levels = c(1:10), labels = c("Clinical Social
Worker","Registered Nurse", "Psychologist", "Psychiatrist", "Nurse Practitioner", "Physician",
"Physicians Assistant", "Osteopathic Doctor", "Gerontologist", "Other"))
table(Thesisdata$Provtype)
# Combining social workers and psychologists, and combining everyone else, to reduce amount
of groups to allow for better analyses of provider type.
Thesisdata$ProvtypeGrp <- recode(Thesisdata$Provtype, recodes = "'Clinical Social Worker' =
'Behavioral Health Training'; 'Psychologist' = 'Behavioral Health Training'; 'Registered Nurse' =
'Medical Training'; 'Psychiatrist' = 'Medical Training'; 'Nurse Practitioner' = 'Medical Training';
'Physician' = 'Medical Training'; 'Physicians Assistant' = 'Medical Training'; 'Other' = NA")
table(Thesisdata$ProvtypeGrp)
# Creating single comp, adhere, educ variables for all respondents ---Thesisdata$Comp <rowMeans(Thesisdata[,c("Competence_1","Competence_2","Competence_3","Competence_4","
Competence_5")], na.rm=TRUE)
Thesisdata$Educ <- rowMeans(Thesisdata[, c("Adherence_4", "Adherence_5")], na.rm=TRUE)
Thesisdata$Adhere <- rowMeans(Thesisdata[, c("Adherence_1", "Adherence_2",
"Adherence_3")],na.rm=TRUE)
# Replace 11 -> NA
Thesisdata$ProvtypeGrp_na<-replace(Thesisdata$ProvtypeGrp, Thesisdata$ProvtypeGrp ==
11, NA)
Thesisdata$Referral_1_na<-replace(Thesisdata$Referral_1, Thesisdata$Referral_1 == 11, NA)
Thesisdata$Referral_2_na<-replace(Thesisdata$Referral_2, Thesisdata$Referral_2 == 11, NA)
Thesisdata$Referral_3_na<-replace(Thesisdata$Referral_3, Thesisdata$Referral_3 == 11, NA)
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# Demographics ---table(Thesisdata$isFemale)
table(Thesisdata$isWhite)
table(Thesisdata$Provtype)
table(Thesisdata$ProvtypeGrp_na)
table(Thesisdata$ProvtypeGrp_na, Thesisdata$Vignette)
table(Thesisdata$Age)
table(Thesisdata$Area)
table(Thesisdata$Area, Thesisdata$Vignette)
table(Thesisdata$Vignette)
# Create clean dataset ---Thesis_final <- data.frame(
"dv_comp" = Thesisdata$Comp,
"dv_adhere" = Thesisdata$Adhere,
"dv_educ" = Thesisdata$Educ,
"dv_weightref" = Thesisdata$Referral_1_na,
"dv_painref" = Thesisdata$Referral_2_na,
"dv_sleepref" = Thesisdata$Referral_3_na,
"iv_vign" = Thesisdata$Vignette,
"cv_provtype" = Thesisdata$ProvtypeGrp_na,
"cv_age" = Thesisdata$Age,
"cv_area" = Thesisdata$Area,
"cv_yearsprac" = Thesisdata$Yearprac)
# Examine to see if age and years in practice are statistically significantly correlated with any
DVs
apa.cor.table(Thesis_final, filename = "ex.cortable1.doc", table.number = NA,
show.conf.interval = TRUE, landscape = TRUE)
# Age and years in practice are not correlated with any DVs and will be dropped from the
analyses
Thesis_final <- data.frame("id" = Thesisdata$subID,
"dv_comp" = Thesisdata$Comp,
"dv_adhere" = Thesisdata$Adhere,
"dv_educ" = Thesisdata$Educ,
"dv_weightref" = Thesisdata$Referral_1_na,
"dv_painref" = Thesisdata$Referral_2_na,
"dv_sleepref" = Thesisdata$Referral_3_na,
"iv_vign" = Thesisdata$Vignette,
"cv_provtype" = Thesisdata$ProvtypeGrp_na,
"cv_area" = Thesisdata$Area)
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# Add columns for older adult an SMI (no, yes)
Thesis_final$OA <- recode(Thesis_final$iv_vign, recodes = "'acomparison' = '0'; 'older adult' =
'1'; 'SMI' = '0'; 'combined' = '1'")
Thesis_final$SMI <- recode(Thesis_final$iv_vign, recodes = "'acomparison' = '0'; 'older adult' =
'0'; 'SMI' = '1'; 'combined' = '1'")
# Statistical Analyses ---# Hypotheses 1 + 2 ---### Adherence ---aovAdhere <- aov(Thesis_final$dv_adhere ~ Thesis_final$OA * Thesis_final$SMI)
Anova(aovAdhere, type = "III")
summary.lm(aovAdhere)
# No statistically significant differences. Will remove interaction variable and rerun model
aovAdhere1 <- aov(Thesis_final$dv_adhere ~ Thesis_final$OA + Thesis_final$SMI)
Anova(aovAdhere1, type = "III")
summary.lm(aovAdhere1)
# No statistically significant differences
apa.1way.table(SMI, dv_adhere, Thesis_final, filename = NA, table.number = NA,
show.conf.interval = FALSE, landscape = FALSE) #SMI
apa.1way.table(OA, dv_adhere, Thesis_final, filename = NA, table.number = NA,
show.conf.interval = FALSE, landscape = FALSE) #OA
apa.1way.table(cv_area, dv_adhere, Thesis_final, filename = NA, table.number = NA,
show.conf.interval = FALSE, landscape = FALSE) #Area
### Competence ---aovComp <- aov(Thesis_final$dv_comp ~ Thesis_final$OA * Thesis_final$SMI)
Anova(aovComp, type = "III")
summary.lm(aovComp)
# No statistically significant results, will remove interaction variable and rerun model
aovComp1 <- aov(Thesis_final$dv_comp ~ Thesis_final$OA + Thesis_final$SMI)
Anova(aovComp1, type = "III")
# SMI was statistically significant, (*F* (1, 138) = 8.11, *p* < .01).
summary.lm(aovComp1)
# Review of the model indicates that omnibus F-test is statistically significant, F(2, 138) = 4.53,
p < .05, R2 = .06.
#Testing normality assumption of residuals for competence
Compmodel <- rstandard(
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lm(dv_comp ~ OA + SMI, data = Thesis_final)
)
Thesis_final$Compmodel[as.numeric(names(Compmodel))] <- Compmodel
# histogram for normality for Competence score
hist(Compmodel, col = 'beige',
main="", xlab = "Competence score",
probability = TRUE)
curve(dnorm(x, mean = mean(Compmodel),
sd = sd(Compmodel)),
add = TRUE, lwd = 2, col = 'blue')
stat.desc(Compmodel, basic = FALSE, norm = TRUE)
# Shapiro-wilks test (*W* = .95, *p* <0.001). Bootstrap sampling will be used
# Bootstrapping
bs <- function(formula,data,indices){
d <- data[indices,]
fit <- lm(formula,data=d)
return(coef(fit))
}
Compboot <- boot(statistic = bs, formula = dv_comp ~ OA + SMI, data = Thesis_final, R =
2000)
boot.ci(Compboot, type = "bca")
# Model is still significant with bootstrap sampling so raw data will be used.
## Testing for homogeniety of variance with residuals
# visualization of homogeneity of variance
boxplot(Thesis_final$Compmodel ~ Thesis_final$OA + Thesis_final$SMI, data = Thesis_final)
# statistical test of homogeneity of variance
leveneTest(y = Thesis_final$Compmodel, group = Thesis_final$iv_vign)
# Assumption of homegeneity was violated for vignette group.
#Welch's F can be used to account for unequal variances
oneway.test(Thesis_final$dv_comp~iv_vign, data = Thesis_final)
# This F value will be used as it does not assume equal variances
#APA table for competence
apa.1way.table(SMI, dv_comp, Thesis_final, filename = "SMIComp.doc", table.number = NA,
show.conf.interval = FALSE, landscape = FALSE) #SMI
# Review of the table shows that providers were more likely to expect individuals with SMI to be
less competent (M = 3.57, SD = .45) compared to individuals without SMI (M = 3.31, SD = .57).
apa.1way.table(OA, dv_comp, Thesis_final, filename = NA, table.number = NA,
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show.conf.interval = FALSE, landscape = FALSE) #OA
apa.1way.table(cv_area, dv_comp, Thesis_final, filename = NA, table.number = NA,
show.conf.interval = FALSE, landscape = FALSE) #Area
### Education ---aovEduc <- aov(Thesis_final$dv_educ ~ Thesis_final$OA * Thesis_final$SMI)
Anova(aovComp, type = "III")
summary.lm(aovComp)
# No statistically significant differences. Will remove interaction variable and rerun model
# Analysis of education without interaction variable
aovEduca <- aov(Thesis_final$dv_educ ~ Thesis_final$OA + Thesis_final$SMI)
Anova(aovEduca, type = "III")
# OA was significant, p < .05
summary.lm(aovEduca)
# Review of the model indicates that omnibus F-test is statistically significant, F(2, 141) = 3.13,
p < .05, R2 = .04.
#Testing normality assumption of residuals for education
Educmodel <- rstandard(
lm(Thesis_final$dv_educ ~ Thesis_final$OA + Thesis_final$SMI, data = Thesis_final)
)
Thesis_final$Educmodel[as.numeric(names(Educmodel))] <- Educmodel
# histogram for normality for Education score
hist(Educmodel, col = 'beige',
main="", xlab = "Education score",
probability = TRUE)
curve(dnorm(x, mean = mean(Educmodel),
sd = sd(Educmodel)),
add = TRUE, lwd = 2, col = 'blue')
stat.desc(Educmodel, basic = FALSE, norm = TRUE)
# Examination of the histogram and the shapiro-wilks test (*W* = .99, *p* = .48) indicate that
the residuals are normally distributed
## Testing for homogeniety of variance with residuals
# visualization of homogeneity of variance
boxplot(Thesis_final$Educmodel ~ Thesis_final$OA + Thesis_final$SMI, data = Thesis_final)
# statistical test of homogeneity of variance
leveneTest(y = Thesis_final$Educmodel, group = Thesis_final$iv_vign)
# Assumptions were not violated. Will continue with analyses
#APA table for education
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apa.1way.table(SMI, dv_educ, Thesis_final, filename = NA, table.number = NA,
show.conf.interval = FALSE, landscape = FALSE) #SMI
apa.1way.table(OA, dv_educ, Thesis_final, filename = NA, table.number = NA,
show.conf.interval = FALSE, landscape = FALSE) #OA
# Review of the table shows that providers were more likely to expect older adults to be to be
less able to read educational material (M = 5.48, SD = 2.04) compared to younger adults (M =
6.29.31, SD = 1.93).
apa.1way.table(cv_area, dv_educ, Thesis_final, filename = NA, table.number = NA,
show.conf.interval = FALSE, landscape = FALSE) #Area
### Weight referral ---aovWeight <- aov(Thesis_final$dv_weightref ~ Thesis_final$OA * Thesis_final$SMI)
Anova(aovWeight, type = "III")
summary.lm(aovWeight)
# No statistically significant differences. Will remove interaction variable and rerun model
# Analysis of weight referral without interaction variable
aovWeighta <- aov(Thesis_final$dv_weightref ~ Thesis_final$OA + Thesis_final$SMI)
Anova(aovWeighta, type = "III")
# SMI was significant, p < .05
summary.lm(aovWeighta)
# Review of the model indicates that omnibus F-test is not statistically significant, F(2, 130) =
2.25, p = .11, R2 = .03.
apa.1way.table(SMI, dv_weightref, Thesis_final, filename = NA, table.number = NA,
show.conf.interval = FALSE, landscape = FALSE) #SMI
apa.1way.table(OA, dv_weightref, Thesis_final, filename = NA, table.number = NA,
show.conf.interval = FALSE, landscape = FALSE) #OA
apa.1way.table(cv_area, dv_weightref, Thesis_final, filename = NA, table.number = NA,
show.conf.interval = FALSE, landscape = FALSE) #Area
### Pain referral ----aovPain <- aov(Thesis_final$dv_painref ~ Thesis_final$OA * Thesis_final$SMI)
Anova(aovPain, type = "III")
summary.lm(aovPain)
# No statistically significant differences. Will remove interaction variable and rerun model
aovPain1 <- aov(Thesis_final$dv_painref ~ Thesis_final$OA + Thesis_final$SMI)
Anova(aovPain1, type = "III")
summary.lm(aovPain1)
# No statistically significant differences
apa.1way.table(SMI, dv_painref, Thesis_final, filename = NA, table.number = NA,
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show.conf.interval = FALSE, landscape = FALSE) #SMI
apa.1way.table(OA, dv_painref, Thesis_final, filename = NA, table.number = NA,
show.conf.interval = FALSE, landscape = FALSE) #OA
apa.1way.table(cv_area, dv_painref, Thesis_final, filename = NA, table.number = NA,
show.conf.interval = FALSE, landscape = FALSE) #Area
### Sleep referral ---aovSleep <- aov(Thesis_final$dv_sleepref ~ Thesis_final$OA * Thesis_final$SMI)
Anova(aovSleep, type = "III")
summary.lm(aovSleep)
# No statistically significant differences. Will remove interaction variable and rerun model
aovSleep1 <- aov(Thesis_final$dv_sleepref ~ Thesis_final$OA + Thesis_final$SMI)
Anova(aovSleep1, type = "III")
# SMI was statistically significant, (*F* (1, 131) = 5.95, *p* < .05).
summary.lm(aovSleep1)
# Review of the model indicates that omnibus F-test is statistically significant, F(2, 131) = 3.22,
p < .05, R2 = .05.
#Testing normality assumption of residuals for sleep referral
Sleepmodel <- rstandard(
lm(Thesis_final$dv_sleepref ~ Thesis_final$OA + Thesis_final$SMI, data = Thesis_final)
)
Thesis_final$Sleepmodel[as.numeric(names(Sleepmodel))] <- Sleepmodel
# histogram for normality for sleep score
hist(Sleepmodel, col = 'beige',
main="", xlab = "Sleep score",
probability = TRUE)
curve(dnorm(x, mean = mean(Sleepmodel),
sd = sd(Sleepmodel)),
add = TRUE, lwd = 2, col = 'blue')
stat.desc(Sleepmodel, basic = FALSE, norm = TRUE)
# Examination of the histogram and the shapiro-wilks test (*W* = .94, *p* < .001) indicate that
the residuals are not normally distributed
# Bootstrapping
bs <- function(formula,data,indices){
d <- data[indices,]
fit <- lm(formula,data=d)
return(coef(fit))
}
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Sleepboot <- boot(statistic = bs, formula = dv_sleepref ~ OA + SMI, data = Thesis_final, R =
2000)
boot.ci(Sleepboot, type = "bca")
# Model is still significant with bootstrap sampling so raw data will be used.
## Testing for homogeniety of variance with residuals
# visualization of homogeneity of variance
boxplot(Thesis_final$Sleepmodel ~ Thesis_final$OA + Thesis_final$SMI, data = Thesis_final)
# statistical test of homogeneity of variance
leveneTest(y = Thesis_final$Sleepmodel, group = Thesis_final$iv_vign)
# Assumptions were not violated. Will continue with analyses
#APA table for sleep referral
apa.1way.table(SMI, dv_sleepref, Thesis_final, filename = NA, table.number = NA,
show.conf.interval = FALSE, landscape = FALSE) #SMI
# Review of the table shows that providers were less likely to make a referral for a sleep study
for individuals with SMI (M = 4.55, SD = 2.86) compared to individuals without SMI (M = 5.80,
SD = 2.96).
apa.1way.table(OA, dv_sleepref, Thesis_final, filename = NA, table.number = NA,
show.conf.interval = FALSE, landscape = FALSE) #OA
apa.1way.table(cv_area, dv_sleepref, Thesis_final, filename = NA, table.number = NA,
show.conf.interval = FALSE, landscape = FALSE) #Area
# Hypothesis 3 ---### Adherence ---aovAdhere2 <- aov(Thesis_final$dv_adhere ~ Thesis_final$OA * Thesis_final$cv_area +
Thesis_final$SMI * Thesis_final$cv_area)
Anova(aovAdhere2, type = "III")
summary.lm(aovAdhere2)
# No statistically significant differences. Will remove interaction variable and rerun model
aovAdhere3 <- aov(Thesis_final$dv_adhere ~ Thesis_final$OA + Thesis_final$SMI
+Thesis_final$cv_area)
Anova(aovAdhere3, type = "III")
# area is statistically significant, p < .05
summary.lm(aovAdhere3)
# However, review of the model indicates that omnibus F-test is not statistically significant, p =
.10
### Competence ---aovComp2 <- aov(Thesis_final$dv_comp ~ Thesis_final$OA * Thesis_final$cv_area +
Thesis_final$SMI * Thesis_final$cv_area)
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Anova(aovComp2, type = "III")
# Neither interaction was statistically significantly different. Will remove interaction variable
and rerun model
# Analysis of competence without interaction variable
aovComp3 <- aov(Thesis_final$dv_comp ~ Thesis_final$OA + Thesis_final$SMI
+Thesis_final$cv_area)
Anova(aovComp3, type = "III")
# SMI is statistically significant, p < .01
summary.lm(aovComp3)
# Review of the model indicates that omnibus F-test is statistically significant, F(3, 137) = 47, p
< .05, R2 = .07.
# However, there were no differences between area so hypothesis 3 was not supported for
competence.
### Education ---aovEduc2 <- aov(Thesis_final$dv_educ ~ Thesis_final$OA * Thesis_final$cv_area +
Thesis_final$SMI * Thesis_final$cv_area)
Anova(aovEduc2, type = "III")
summary.lm(aovEduc2)
# Neither interaction was statistically significantly different. Will remove interaction variable
and rerun model
# Analysis of education without interaction variable
aovEduc3 <- aov(Thesis_final$dv_educ ~ Thesis_final$OA + Thesis_final$SMI
+Thesis_final$cv_area)
Anova(aovEduc3, type = "III")
# OA was significant, p < .05
summary.lm(aovEduc3)
# Review of the model indicates that omnibus F-test is trending towards significance, F(3, 140) =
2.66, p = .05, R2 = .05.
# However, there were no differences between area so hypothesis 3 was not supported
### Weight referral ---aovWeight2 <- aov(Thesis_final$dv_weightref ~ Thesis_final$OA * Thesis_final$cv_area +
Thesis_final$SMI * Thesis_final$cv_area)
Anova(aovWeight2, type = "III")
summary.lm(aovWeight2)
# Neither interaction was statistically significantly different. Will remove interaction variable
and rerun model
# Analysis of weight referral without interaction variable
aovWeight3 <- aov(Thesis_final$dv_weightref ~ Thesis_final$OA + Thesis_final$SMI +
Thesis_final$cv_area)
Anova(aovWeight3, type = "III")
# SMI and Area are trending towards significance, p = .06 and p = .07 respectively.
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summary.lm(aovWeight3)
# Review of the model indicates that omnibus F-test is trending towards significance, F(3, 129) =
2.61, p = .05, R2 = .06.
### Pain referral ---aovPain2 <- aov(Thesis_final$dv_painref ~ Thesis_final$OA * Thesis_final$cv_area +
Thesis_final$SMI * Thesis_final$cv_area)
Anova(aovPain2, type = "III")
# The interaction of area and SMI were statistically significant, p < .05. The non significant
interaction will be removed and the model will be rerun.
summary.lm(aovPain2)
# Review of the model indicates that omnibus F-test is not statistically significant, F(5, 128) =
1.72, p = .13, R2 = .06.
# Analysis of pain referral without interaction variable
aovPain3 <- aov(Thesis_final$dv_painref ~ Thesis_final$OA + Thesis_final$SMI *
Thesis_final$cv_area)
Anova(aovPain3, type = "III")
# Area and the interaction between area and SMI were statistically significant, p < .01 and p <
.05 respectively.
summary.lm(aovPain3)
# Review of the model indicates that omnibus F-test is trending towards significance, F(3, 129) =
2.11, p = .08, R2 = .06.
# Hypothesis 3 not supported
### Sleep referral ---aovSleep2 <- aov(Thesis_final$dv_sleepref ~ Thesis_final$OA * Thesis_final$cv_area +
Thesis_final$SMI * Thesis_final$cv_area)
Anova(aovSleep2, type = "III")
summary.lm(aovSleep2)
# Neither interaction was statistically significantly different. Will remove interaction variable
and rerun model
# Analysis of sleep referral without interaction variable
aovSleep3 <- aov(Thesis_final$dv_sleepref ~ Thesis_final$OA + Thesis_final$SMI
+Thesis_final$cv_area)
Anova(aovSleep3, type = "III")
# SMI was statistically significant, p < .05
summary.lm(aovSleep3)
# Review of the model indicates that omnibus F-test is not significant, F(3, 130) = 2.16, p = .09,
R2 = .05.
# Hypothesis 3 not supported
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